Search Results

You searched for "breast cancer". We found 10 journal(s).

 

Cancer Management and Research

OncoTargets and Therapy

Oncolytic Virotherapy

Biologics: Targets and Therapy

You searched for "breast cancer". We found 7956 paper(s).

 

Preclinical quantification of air leaks in a physiologic lung model: effects of ventilation modality and staple design

Eckert CE, Harris JL, Wong JB, Thompson S, Kassis ES, Tsuboi M, Ott HC, Force S

Medical Devices: Evidence and Research 2018, 11:433-442

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease

Igawa S, Nishinarita N, Takakura A, Ozawa T, Harada S, Kusuhara S, Niwa H, Hosotani S, Sone H, Nakahara Y, Fukui T, Mitsufuji H, Yokoba M, Kubota M, Katagiri M, Sasaki J, Naoki K

Cancer Management and Research 2018, 10:7013-7019

Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study

Yao JJ, Zhang F, Zhang GS, Deng XW, Zhang WJ, Lawrence WR, Zou L, Zhang XS, Lu LX

Cancer Management and Research 2018, 10:6985-6996

Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival

Wang X, Chen D, Gao J, Long H, Zha H, Zhang A, Shu C, Zhou L, Yang F, Zhu B, Wu W

Cancer Management and Research 2018, 10:6971-6984

Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma

Miyake M, Owari T, Hori S, Nakai Y, Fujimoto K

Research and Reports in Urology 2018, 10:251-261

Natural antisense transcript of hypoxia-inducible factor 1 regulates hypoxic cell apoptosis in epithelial ovarian cancer

Qiu J, Lin X, Zheng T, Tang X, Hua K

OncoTargets and Therapy 2018, 11:9101-9110

An individual reference limit of the serum CEA–TPA–CA 15-3 tumor marker panel in the surveillance of asymptomatic women following surgery for primary breast cancer

Nicolini A, Carpi A, Ferrari P, Morganti R, Mazzotti V, Barak V, Duffy MJ

Cancer Management and Research 2018, 10:6879-6886

Positive relationship between number of negative lymph nodes and duration of gallbladder cancer cause-specific survival after surgery

Lin JY, Bai DS, Zhou BH, Chen P, Qian JJ, Jin SJ, Jiang GQ

Cancer Management and Research 2018, 10:6961-6969

Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma

Li Y, Bian XH, Ouyang JY, Wei SY, He MZ, Luo ZL

Cancer Management and Research 2018, 10:6949-6959

Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer

Zhou Q, Hou CN, Yang HJ, He Z, Zuo MZ

Cancer Management and Research 2018, 10:6937-6948

Gamma linolic acid regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DEN induced Hepatocellular carcinoma

Cui H, Han F, Zhang L, Wang L, Kumar M

Drug Design, Development and Therapy 2018, 12:4241-4252

Age should not be a limiting factor in laparoscopic surgery: a prospective multicenter cohort study on quality of life after laparoscopic hysterectomy

Briët JM, Mourits MJE, van Leeuwen BL, van den Heuvel ER, Kenkhuis MJA, Arts HJG, de Bock GH

Clinical Interventions in Aging 2018, 13:2517-2526

The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis

Chen J, Zhang X, Sun G, Zhao J, Liu J, Zhao P, Dai J, Shen P, Zeng H

OncoTargets and Therapy 2018, 11:9061-9070

Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study

Chen C, Huang S, Huang A, Jia Y, Wang J, Zhang Z, Mao M, Wang L, Zhou J

OncoTargets and Therapy 2018, 11:9071-9080

TSPAN7 promotes the migration and proliferation of lung cancer cells via epithelial-to-mesenchymal transition

Wang X, Lin M, Zhao J, Zhu S, Xu M, Zhou X

OncoTargets and Therapy 2018, 11:8815-8822

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer

Jiang X, Wu M, Xu Z, Wang H, Wang H, Yu X, Li Z, Teng L

Cancer Management and Research 2018, 10:6857-6867

The number of resected lymph nodes is associated with the long-term survival outcome in patients with T2 N0 non-small cell lung cancer

Wen YS, Xi KX, Xi KX, Zhang RS, Wang GM, Huang ZR, Zhang LJ

Cancer Management and Research 2018, 10:6869-6877

Epidemiological profiles of chronic low back and knee pain in middle-aged and elderly Japanese from the Murakami cohort

Takahashi A, Kitamura K, Watanabe Y, Kobayashi R, Saito T, Takachi R, Kabasawa K, Oshiki R, Tsugane S, Iki M, Sasaki A, Yamazaki O, Nakamura K

Journal of Pain Research 2018, 11:3161-3169

c.1439delA frameshift deletion mutation in familial adenomatous polyposis

Ma DJ, Wang BS, Yue JB, Li ZJ, Sun YL

OncoTargets and Therapy 2018, 11:8987-8993

Nomograms for predicting survival outcomes in patients with primary tracheal tumors: a large population-based analysis

Wen J, Liu D, Xu X, Chen D, Chen Y, Sun L, Chen J, Fan M

Cancer Management and Research 2018, 10:6843-6856

Biological therapy for the treatment of prepouch ileitis: a retrospective observational study from three centers

Segal JP, Rottoli M, Felwick RK, Worley GHT, McLaughlin SD, Vallicelli C, Bassett P, Faiz OD, Hart AL, Clark SK

Clinical and Experimental Gastroenterology 2018, 11:461-465

Olaparib nanoparticles potentiated radiosensitization effects on lung cancer

Wu M, Liu J, Hu C, Li D, Yang J, Wu Z, Yang L, Chen Y, Fu S, Wu J

International Journal of Nanomedicine 2018, 13:8461-8472

Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells

Li X, Zhu G, Yao X, Wang N, Hu R, Kong Q, Zhou D, Long L, Cai J, Zhou W

OncoTargets and Therapy 2018, 11:8977-8985

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms

Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA

OncoTargets and Therapy 2018, 11:8937-8942

Patient-delivered tDCS on chronic neuropathic pain in prior responders to TMS (a randomized controlled pilot study)

O'Neill F, Sacco P, Bowden E, Asher R, Burnside G, Cox T, Nurmikko T

Journal of Pain Research 2018, 11:3117-3128

The clinical promise of immunotherapy in triple-negative breast cancer

Vikas P, Borcherding N, Zhang W

Cancer Management and Research 2018, 10:6823-6833

A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology

Liu H, Du K, Li D, Du Y, Xi J, Xu Y, Shen Y, Jiang T, Webster TJ

International Journal of Nanomedicine 2018, 13:8379-8393

Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy

Zhang P, Ren Z, Chen Z, Zhu J, Liang J, Liao R, Wen J

Drug Design, Development and Therapy 2018, 12:4207-4216

Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis

Sun TT, Tang YR, Sun DW, Bu Q, Li P

OncoTargets and Therapy 2018, 11:8925-8935

Drug–target–disease network analysis of gene–phenotype connectivity for genistein in ovarian cancer

Zhang C, Yang F, Ni S, Teng W, Ning Y

OncoTargets and Therapy 2018, 11:8901-8908

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

De Carlo E, Schiappacassi M, Urbani M, Doliana R, Baldassarre G, Da Ros V, Santarossa S, Chimienti E, Berto E, Fratino L, Bearz A

OncoTargets and Therapy 2018, 11:8945-8950

TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial–mesenchymal transition in gastric cancer

Chen D, You X, Pan Y, Liu Q, Cao G

OncoTargets and Therapy 2018, 11:8803-8813

Prognosis of rare pathological primary urethral carcinoma

Abudurexiti M, Wang J, Shao N, Wan FN, Zhu Y, Dai B, Ye D

Cancer Management and Research 2018, 10:6815-6822

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A

OncoTargets and Therapy 2018, 11:8823-8833

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway

Tang Z, Cai H, Wang R, Cui Y

OncoTargets and Therapy 2018, 11:8875-8883

Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93

Xu F, Zha G, Wu Y, Cai W, Ao J

OncoTargets and Therapy 2018, 11:8855-8863

miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression

Peng X, Guan L, Gao B

OncoTargets and Therapy 2018, 11:8865-8874

Predictive value of positron emission tomography for the prognosis of molecularly targeted therapy in solid tumors

Xie X, Chen H, Yang H, Lin H, Zhou S, Shen R, Lu C, Ling L, Lin W, Liao Z

OncoTargets and Therapy 2018, 11:8885-8899

Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer

Godinho MV, Lopes FP, Costa FM

Cancer Management and Research 2018, 10:6743-6756

Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells

Li X, Wang W, Fan Y, Wei Y, Yu LQ, Wei JF, Wang YF

Cancer Management and Research 2018, 10:6715-6729

Comparison of totally laparoscopic and open approach in total gastrectomy with D2 lymphadenectomy – systematic review and meta-analysis

Małczak P, Torbicz G, Rubinkiewicz M, Gajewska N, Sajuk N, Rozmus K, Wysocki M, Major P, Budzyński A, Pędziwiatr M

Cancer Management and Research 2018, 10:6705-6714

Low STYK1 expression indicates poor prognosis in gastric cancer

Fang J, Wang H, Fang X, Li N, Hu H, Bian M, Yang P

Cancer Management and Research 2018, 10:6669-6676

Comparison between NOD/SCID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer

Wu J, Zhang J, Jiang M, Zhang T, Wang Y, Wang Z, Miao Y, Wang Z, Li W

Cancer Management and Research 2018, 10:6695-6703

MALAT1: a potential biomarker in cancer

Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G, Zhu YS

Cancer Management and Research 2018, 10:6757-6768

Online support community for adolescents and young adults (AYAs) with cancer: user statistics, evaluation, and content analysis

Kaal SEJ, Husson O, van Dartel F, Hermans K, Jansen R, Manten-Horst E, Servaes P, van de Belt TH, Engelen LJLPG, Prins JB, Verberne S, van der Graaf WTA

Patient Preference and Adherence 2018, 12:2615-2622

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

Castellan P, Marchioni M, Castellucci R, De Francesco P, Iantorno R, Schips L, Cindolo L

Therapeutics and Clinical Risk Management 2018, 14:2341-2347

miR-1 inhibits the proliferation of breast cancer stem cells by targeting EVI-1

Wu L, Wang T, He D, Li X, Jiang Y

OncoTargets and Therapy 2018, 11:8773-8781

MicroRNA-486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells

Feng L, Jing L, Han J, Wang G, Liu Y, Zhang X, Wang Y, Wang F, Ma H, Liu Y

OncoTargets and Therapy 2018, 11:8791-8801

PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis

Gao CL, Sun R, Li DH, Gong F

OncoTargets and Therapy 2018, 11:8783-8789

Bacterial profile of infant feces associated with lactation infectious breasts

Tsunoda Y, Asahara T, Nomoto K, Yoshioka Y, Fukuma E

Pediatric Health, Medicine and Therapeutics 2018, 9:173-180

Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2

Kostrzewa T, Sahu KK, Gorska-Ponikowska M, Tuszynski JA, Kuban-Jankowska A

Drug Design, Development and Therapy 2018, 12:4139-4147

IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis

Browning L, Patel MR, Bring Horvath E, Tawara K, Jorcyk CL

Cancer Management and Research 2018, 10:6685-6693

Total endoscopic thyroidectomy versus conventional open thyroidectomy in thyroid cancer: a systematic review and meta-analysis

Chen C, Huang S, Huang A, Jia Y, Wang J, Mao M, Zhou J, Wang L

Therapeutics and Clinical Risk Management 2018, 14:2349-2361

Overexpression of NELFCD promotes colorectal cancer cells proliferation, migration, and invasion

Song S, Li D, Yang C, Yan P, Bai Y, Zhang Y, Hu G, Lin C, Li X

OncoTargets and Therapy 2018, 11:8741-8750

Elevated FAM3C promotes cell epithelial–mesenchymal transition and cell migration in gastric cancer

Shi M, Duan G, Nie S, Shen S, Zou X

OncoTargets and Therapy 2018, 11:8491-8505

Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer

Zhang Y, Huang F, Luo Q, Wu X, Liu Z, Chen H, Huang Y

OncoTargets and Therapy 2018, 11:8751-8759

Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients

Feldheim J, Kessler AF, Schmitt D, Wilczek L, Linsenmann T, Dahlmann M, Monoranu CM, Ernestus RI, Hagemann C, Löhr M

OncoTargets and Therapy 2018, 11:8673-8684

The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts

Polachek H, Debotton N, Feinshtein V, Rubin M, Ben-Zvi Z, Holcberg G, Agbaria R, Dahan A

Drug Design, Development and Therapy 2018, 12:4129-4138

Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells

Wang J, Liu C, Chang X, Qi Y, Zhu Z, Yang X

Cancer Management and Research 2018, 10:6641-6647

A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer

Yang H, Li X, Shi J, Fu H, Yang H, Liang Z, Xiong H, Wang H

Cancer Management and Research 2018, 10:6611-6626

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients

Xiong G, Yao L, Hong P, Yang L, Ci W, Liu L, He Q, Gong K, Li X, Zhou L

Cancer Management and Research 2018, 10:6627-6639

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro

Long R, Dai Q, Zhou X, Cai D, Hong Y, Wang SB, Liu Y

International Journal of Nanomedicine 2018, 13:8269-8279

Highly stable RGD/disulfide bridge-bearing star-shaped biodegradable nanocarriers for enhancing drug-loading efficiency, rapid cellular uptake, and on-demand cargo release

Yan J, Zhang H, Cheng F, He Y, Su T, Zhang X, Zhang M, Zhu Y, Li C, Cao J, He B

International Journal of Nanomedicine 2018, 13:8247-8268

Development and validation of a prognostic signature for preoperative prediction of overall survival in gastric cancer patients

Zhu M, Wang Q, Luo Z, Liu K, Zhang Z

OncoTargets and Therapy 2018, 11:8711-8722

MiR-411 suppresses the development of bladder cancer by regulating ZnT1

Liu Y, Liu T, Jin H, Yin L, Yu H, Bi J

OncoTargets and Therapy 2018, 11:8695-8704

Intestinal metastasis from breast invasive ductal carcinoma after a long latency: case report and literature review

Liu M, Zhang L, Guo L, Lv J, Shi W, Liu B

OncoTargets and Therapy 2018, 11:8599-8603

Long non-coding RNA 1308 promotes cell invasion by regulating the miR-124/ADAM 15 axis in non-small-cell lung cancer cells

Li H, Guo X, Li Q, Ran P, Xiang X, Yuan Y, Dong T, Zhu B, Wang L, Li F, Yang C, Mu D, Wang D, Xiao C, Zheng S

Cancer Management and Research 2018, 10:6599-6609

Classification of positive surgical margins and tumor recurrence after nephron-sparing surgery for small renal masses

Li G, Zhu DS, Lang ZQ, Wang AX, Li YH, Zhang RY, Niu YJ

Cancer Management and Research 2018, 10:6591-6598

Palliative care: needs of advanced breast cancer patients

Cherny NI, Paluch-Shimon S, Berner-Wygoda Y

Breast Cancer: Targets and Therapy 2018, 10:231-243

Evidence for improvements to risk stratification in high-risk gastrointestinal stromal tumor patients

Greco A, Rossi S, Ruffolo C, Pauletti B, Dei Tos AP, Morana G, Massani M

Gastrointestinal Cancer: Targets and Therapy 2018, 8:25-36

A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model

Park S, Kim D, Wu G, Jung H, Park JA, Kwon HJ, Lee Y

OncoTargets and Therapy 2018, 11:8655-8672

Encapsulation of chloroquine and doxorubicin by MPEG-PLA to enhance anticancer effects by lysosomes inhibition in ovarian cancer

Shao M, Zhu WT, Lv XP, Yang QK, Liu X, Xie Y, Tang P, Sun L

International Journal of Nanomedicine 2018, 13:8231-8245

The synergistic effect of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside combined with Adriamycin on MCF-7 breast cancer cells

Shen JF, Zhang YZ, Shen H, Pan H, Xu LS, Yuan LN, Ding ZY

Drug Design, Development and Therapy 2018, 12:4083-4094

Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India

Mehta A, Vasudevan S, Sharma SK, Kumar D, Panigrahi M, Suryavanshi M, Gupta G

Cancer Management and Research 2018, 10:6505-6516

The clinical significance of CCBE1 expression in human colorectal cancer

Zhao YR, Liu H, Xiao LM, Jin CG, Zhang ZP, Yang CG

Cancer Management and Research 2018, 10:6581-6590

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, El Shafie RA, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S

Cancer Management and Research 2018, 10:6563-6569

Artificial intelligence methods for the diagnosis of breast cancer by image processing: a review

Sadoughi F, Kazemy Z, Hamedan F, Owji L, Rahmanikatigari M, Talebi Azadboni T

Breast Cancer: Targets and Therapy 2018, 10:219-230

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

Wen M, Xia J, Sun Y, Wang X, Fu X, Zhang Y, Zhang Z, Zhou Y, Li X

Biologics: Targets and Therapy 2018, 12:183-190

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial

Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C

OncoTargets and Therapy 2018, 11:8575-8587

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L

OncoTargets and Therapy 2018, 11:8565-8573

Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action

Talib WH, Al-hadid SA, Wild Ali MB, AL-Yasari IH, Abd Ali MR

Breast Cancer: Targets and Therapy 2018, 10:207-217

Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy

Liu L, Xie HJ, Mu LM, Liu R, Su ZB, Cui YN, Xie Y, Lu WL

International Journal of Nanomedicine 2018, 13:8119-8135

Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment

Baldwin P, Ohman AW, Tangutoori S, Dinulescu DM, Sridhar S

International Journal of Nanomedicine 2018, 13:8063-8074

Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma

Braham MVJ, Deshantri AK, Minnema MC, Öner FC, Schiffelers RM, Fens MHAM, Alblas J

International Journal of Nanomedicine 2018, 13:8105-8118

Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells

Abou-El-Naga AM, Mutawa G, El-Sherbiny IM, Mousa SA

International Journal of Nanomedicine 2018, 13:8153-8164

Gold nanoparticles – an optical biosensor for RNA quantification for cancer and neurologic disorders diagnosis

Shawky SM, Awad AM, Abugable AA, El-Khamisy SF

International Journal of Nanomedicine 2018, 13:8137-8151

miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer

Fang Y, Liang X, Xu J, Cai X

Cancer Management and Research 2018, 10:6537-6547

Breast cancer laterality and molecular subtype likely share a common risk factor

Cheng SA, Liang LZ, Liang QL, Huang ZY, Peng XX, Hong XC, Luo XB, Yuan GL, Zhang HJ, Jiang L

Cancer Management and Research 2018, 10:6549-6554

STAT1 inhibits STAT3 activation in esophageal squamous cell carcinoma

Liu Z, Zhang Y, Chen Y, Lin Y, Lin Z, Wang H

Cancer Management and Research 2018, 10:6517-6523

Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

Mohieldin A, Rasmy A, Ashour M, Al-Nassar M, Ali RH, El-Enezi FG

Cancer Management and Research 2018, 10:6555-6561

Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells

Yang Y, Zhu F, Wang Q, Ding Y, Ying R, Zeng L

OncoTargets and Therapy 2018, 11:8455-8463

Vandetanib (ZD6474) induces antiangiogenesis through mTOR–HIF-1 alpha–VEGF signaling axis in breast cancer cells

Li L, Yu J, Jiao S, Wang W, Zhang F, Sun S

OncoTargets and Therapy 2018, 11:8543-8553

High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis

Liu Q, Li W, Yang S, Liu Z

OncoTargets and Therapy 2018, 11:8427-8434

Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk

Miao Z, Deng X, Shuai P, Zeng J

OncoTargets and Therapy 2018, 11:8481-8490

lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346

Pan RS, He ZX, Ruan WY, Li S, Chen H, Chen ZY, Liu F, Tian XB, Nie YJ

OncoTargets and Therapy 2018, 11:8409-8420

Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Tang L, Wu J, Cai S, Huang Y, Zhang X, Fu W, Zhuang Q, Li J

OncoTargets and Therapy 2018, 11:8507-8515

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

Zhao JJ, Zhou ZQ, Wang P, Chen CL, Liu Y, Pan QZ, Zhu Q, Tang Y, Weng DS, Xia JC

Cancer Management and Research 2018, 10:6457-6468

Managing the cancer–work interface: the effect of cancer survivorship on unemployment

Tracy JK, Falk D, Thompsom RJ, Scheindlin L, Adetunji F, Swanberg JE

Cancer Management and Research 2018, 10:6479-6487

Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases

Shang S, Su Y, Zhu Z, Li B, Guo M, Xu Y, Sun X, Wang L, Yu J

Cancer Management and Research 2018, 10:6421-6429

Specific clinical and immune features of CD68 in glioma via 1,024 samples

Wang L, Zhang C, Zhang Z, Han B, Shen Z, Li L, Liu S, Zhao X, Ye F, Zhang Y

Cancer Management and Research 2018, 10:6409-6419

NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells

Wang Q, Wang C, Chen J

Cancer Management and Research 2018, 10:6431-6444

GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer

Liu Y, Shao L, Chen K, Wang Z, Wang J, Jing W, Hu M

OncoTargets and Therapy 2018, 11:8371-8379

Prognostic roles of mRNA expression of peroxiredoxins in lung cancer

Chen L, Huang C, Yang X, Zhang Q, Chen F

OncoTargets and Therapy 2018, 11:8381-8388

Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis

Han W, Wang Y, Fan J, Wang C

OncoTargets and Therapy 2018, 11:8359-8369

A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark

Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P

Clinical Epidemiology 2018, 10:1755-1763

Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer

Yazarlou F, Modarressi MH, Mowla SJ, Kholghi Oskooei V, Motevaseli E, Farhady Tooli L, Nekoohesh L, Eghbali M, Ghafouri-Fard S, Afsharpad M

Cancer Management and Research 2018, 10:6357-6365

Integrated mitochondrial function and cancer-related fatigue in men with prostate cancer undergoing radiation therapy

Hsiao CP, Chen MK, Daly B, Hoppel C

Cancer Management and Research 2018, 10:6367-6377

Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway

Zhou Q, Jiang H, Zhang J, Yu W, Zhou Z, Huang P, Wang J, Xiao Z

Cancer Management and Research 2018, 10:6339-6355

Combined fibrinogen and neutrophil–lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma

Li X, An B, Zhao Q, Qi J, Wang W, Zhang D, Li Z, Qin C

Cancer Management and Research 2018, 10:6285-6294

Sub-10 nm Cu5FeS4 cube for magnetic resonance imaging-guided photothermal therapy of cancer

Wang D, Zhang Y, Guo Q

International Journal of Nanomedicine 2018, 13:7987-7996

MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial–mesenchymal transition in lung cancer cells [Corrigendum]

Pan B, Han H, Wu L, Xiong Y, Zhang J, Dong B, Yang Y, Chen J

OncoTargets and Therapy 2018, 11:8357-8358

TGF-beta 1 levels are associated with lymphocyte percentages in patients with lung cancer treated with radiation therapy

Luo J, Hu S, Wei T, Sun J, Liu N, Wang J

OncoTargets and Therapy 2018, 11:8349-8355

Afatinib reverses ceritinib resistance (CR) in ALK/ROS1-positive non-small-cell lung cancer cell (NSCLC) via suppression of NRG1 pathway

Chen H, Zhang Q, Zhang Y, Jia B, Zhang B, Wang C

OncoTargets and Therapy 2018, 11:8201-8209

Development and applications of oncolytic Maraba virus vaccines

Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD

Oncolytic Virotherapy 2018, 7:117-128

Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases

Tsunoda Y, Sasaki A, Sakamoto N, Teraoka K, Nakagawa R, Koshida Y, Fukuma E

Breast Cancer: Targets and Therapy 2018, 10:195-199

Vascular targeted nanotherapeutic approach for obesity treatment

Sibuyi NRS, Meyer M, Onani MO, Skepu A, Madiehe AM

International Journal of Nanomedicine 2018, 13:7915-7929

Upregulation of KIF20A correlates with poor prognosis in gastric cancer

Sheng Y, Wang W, Hong B, Jiang X, Sun R, Yan Q, Zhang S, Lu M, Wang S, Zhang Z, Lin W, Li Y

Cancer Management and Research 2018, 10:6205-6216

Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer

Zhao K, Jin S, Wei B, Cao S, Xiong Z

Cancer Management and Research 2018, 10:6257-6261

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K

OncoTargets and Therapy 2018, 11:8301-8307

Prognostic significance of mammary Paget’s disease in Chinese women: a 10 year, population-based, matched cohort study

Zhou H, Lu K, Zheng L, Guo L, Gao Y, Miao X, Chen Z, Wang X

OncoTargets and Therapy 2018, 11:8319-8326

Trends in incidence and mortality of female breast cancer during transition in Central China

Cheng Y, Yan Y, Gong J, Yang N, Nie S

Cancer Management and Research 2018, 10:6247-6255

Glucose deprivation promotes apoptotic response to S1 by enhancing autophagy in human cervical cancer cells

Zhou L, Kong QH, Zhang YH, Yang W, Yan S, Li MH, Wang YD, Zhou YJ, Yu HM, Han LY

Cancer Management and Research 2018, 10:6195-6204

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:791-806

Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center

Xiao BY, Peng JH, Tang JH, Zhang RX, Li C, Lin JZ, Ding PR, Wan DS, Pan ZZ, Wu XJ

Cancer Management and Research 2018, 10:6121-6127

Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer

Deng JQ, Ren ZP, Wen JX, Wang B, Hou XB, Xue ZQ, Chu XY

Cancer Management and Research 2018, 10:6143-6156

miRNA-299-5p regulates estrogen receptor alpha and inhibits migration and invasion of papillary thyroid cancer cell

Wang Z, He L, Sun W, Qin Y, Dong W, Zhang T, Zhang P, Zhang H

Cancer Management and Research 2018, 10:6181-6193

ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer

Guo XB, Huang B, Pan YH, Su SG, Li Y

Cancer Management and Research 2018, 10:6157-6166

Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients

Jonska-Gmyrek J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, Fuksiewicz M, Kotowicz B

Cancer Management and Research 2018, 10:6029-6038

Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4

Lian H, Jia X, Shi N, Xie S, Wang J, Wang W, Ma F, Liu H, Wang A, Cheng X, Liu C

Cancer Management and Research 2018, 10:6129-6141

Value of plasma SN-38 levels and DPD activity in irinotecan-based individualized chemotherapy for advanced colorectal cancer with heterozygous type UGT1A1*6 or UGT1A1*28

Tian C, Ying HF, Zhuang RY, Zhang XW, Lu HM, Wang H, Wang SW, Li Q, Wang CG, Cai X

Cancer Management and Research 2018, 10:6217-6226

Fabrication and evaluation of a γ-PGA-based self-assembly transferrin receptor-targeting anticancer drug carrier

Zhang L, Zhu X, Wu S, Chen Y, Tan S, Liu Y, Jiang W, Huang J

International Journal of Nanomedicine 2018, 13:7873-7889

The effect of piperlongumine on endothelial and lung adenocarcinoma cells with regulated expression of profilin-1

Gagat M, Hałas-Wiśniewska M, Zielińska W, Izdebska M, Grzanka D, Grzanka A

OncoTargets and Therapy 2018, 11:8275-8292

Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy

Wang NN, Fan RE, Leppert JT, Ghanouni P, Kunder CA, Brooks JD, Chung BI, Sonn GA

Research and Reports in Urology 2018, 10:233-235

Effects of quercetin and arginine on the nephrotoxicity and lipid peroxidation induced by gold nanoparticles in vivo

Abdelhalim MAK, Qaid HAY, Al-Mohy Y, Al-Ayed MS

International Journal of Nanomedicine 2018, 13:7765-7770

89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior

Hajdu I, Makhlouf A, Solomon VR, Michel D, Al-Dulaymi M, Wasan KM, Fonge H, Badea I

International Journal of Nanomedicine 2018, 13:7801-7818

Biogenic pentagonal silver nanoparticles for safer and more effective antibacterial therapeutics

Khan S, Ahmad K, Ahmad A, Raish M, Jan BL, Khan A, Khan MS

International Journal of Nanomedicine 2018, 13:7789-7799

Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry

Linauskas A, Overvad K, Johansen MB, Stengaard-Pedersen K, de Thurah A

Clinical Epidemiology 2018, 10:1709-1720

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy

Yeh CN, Wu RC, Cheng CT, Tsai CY, Chang YR, Yeh TS, Wu TH, Lee WC, Chiang KC

Cancer Management and Research 2018, 10:6049-6059

Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery

Chen D, Wang W, Chen Y, Hu J, Yang M, Mo J, Wen Z

Cancer Management and Research 2018, 10:6109-6120

Radiotherapy as salvage treatment of salivary duct carcinoma in major salivary glands without radical operations

Di L, Qian K, Du C, Shen C, Zhai R, He X, Wang X, Xu T, Hu C, Ying H

Cancer Management and Research 2018, 10:6071-6078

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

Shirasawa M, Fukui T, Kusuhara S, Hiyoshi Y, Ishihara M, Kasajima M, Nakahara Y, Otani S, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K

Cancer Management and Research 2018, 10:6039-6047

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma

Zheng YJ, Liu YL, Zhao SF, Zheng ZT, Shen CY, An L, Yuan YL

Cancer Management and Research 2018, 10:6079-6096

A Phase II study of S-1 plus oral leucovorin in heavily treated metastatic colorectal cancer patients

Hsu HC, Chou WC, Kuan FC, Lee KD, Rau KM, Huang JS, Yang TS

Cancer Management and Research 2018, 10:6061-6070

Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma

Song YJ, Tan J, Gao XH, Wang LX

Cancer Management and Research 2018, 10:6097-6108

Platelets enhance the ability of bone-marrow mesenchymal stem cells to promote cancer metastasis

Wang Q, Li Z, Sun L, Chen B, Zhao Y, Shen B, Zhu M, Zhao X, Xu C, Wang M, Xu W, Zhu W

OncoTargets and Therapy 2018, 11:8251-8263

Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity

Alimoradi H, Greish K, Barzegar-Fallah A, Alshaibani L, Pittalà V

International Journal of Nanomedicine 2018, 13:7771-7787

Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo

Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M

International Journal of Nanomedicine 2018, 13:7727-7747

Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity

Wang W, Dou S, Dong W, Xie M, Cui L, Zheng C, Xiao W

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3767-3776

U94/rep of human herpesvirus 6 inhibits proliferation, invasion, and angiogenesis of glioma

Gu B, Li L, Li M, Wang J, Zhang G, Yao K, Wang S

Cancer Management and Research 2018, 10:5991-6001

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis

Zhang S, Xie W, Zou Y, Xie S, Zhang J, Yuan W, Ma J, Zhao J, Zheng C, Chen Y, Wang C

Cancer Management and Research 2018, 10:5965-5978

Assessment of the effectiveness of PMTCT program in eight service delivery points in North Central Nigeria

Oleribe OO, Enenche E, Udofia D, Ekom E, Osita-Oleribe PI, Kim JU, Taylor-Robinson SD

HIV/AIDS - Research and Palliative Care 2018, 10:253-259

Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme

Burton C, Das A, McDonald D, Vandergrift III WA, Patel SJ, Cachia D, Bartee E

Oncolytic Virotherapy 2018, 7:107-116

Tailor-made PL-UC-C3 nanoparticles for fluorescence/computed tomography imaging-guided cascade amplified photothermal therapy

Xie X, Song J, Hu Y, Zhuang S, Wang Y, Zhao Y, Lu Q

International Journal of Nanomedicine 2018, 13:7633-7646

Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts

Christensen E, Henriksen JR, Jørgensen JT, Amitay Y, Shmeeda H, Gabizon A, Kjær A, Andresen TL, Hansen AE

International Journal of Nanomedicine 2018, 13:7647-7656

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

Journal of Hepatocellular Carcinoma 2018, 5:109-119

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer

Guo LW, Jiang LM, Gong Y, Zhang HH, Li XG, He M, Sun WL, Ling H, Hu X

Cancer Management and Research 2018, 10:5881-5894

Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study

Zuo N, Hu H, Thapa N, Li Z, Jiang D, Meng X, Yang J, Chen X, Cai H

Cancer Management and Research 2018, 10:5927-5935

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R

Cancer Management and Research 2018, 10:5909-5917

Aberrant prefrontal–parietal–cerebellar circuits in alcohol dependence

Liu R, Liu BX, Ma M, Kong D, Li G, Yang J, Wu X, Zheng J, Dong Y

Neuropsychiatric Disease and Treatment 2018, 14:3143-3150

Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma

Wang SJ, Wang Q, Zhang X, Liao X, Wang G, Yu L, Zhang W, Zhou Q, Hu S, Yuan W

Cancer Management and Research 2018, 10:5807-5824

FPR1 mediates the tumorigenicity of human cervical cancer cells

Cao G, Zhang Z

Cancer Management and Research 2018, 10:5855-5865

12-HETE facilitates cell survival by activating the integrin-linked kinase/NF-κB pathway in ovarian cancer

Liu Q, Tan W, Che J, Yuan D, Zhang L, Sun Y, Yue X, Xiao L, Jin Y

Cancer Management and Research 2018, 10:5825-5838

A 15-lncRNA signature predicts survival and functions as a ceRNA in patients with colorectal cancer

Wang X, Zhou J, Xu M, Yan Y, Huang L, Kuang Y, Liu Y, Li P, Zheng W, Liu H, Jia B

Cancer Management and Research 2018, 10:5799-5806

CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis

Ortiz-Montero P, Liu-Bordes WY, Londoño-Vallejo A, Vernot JP

Cancer Management and Research 2018, 10:5767-5784

Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis

Zhang T, Feng F, Zhao W, Yao Y, Tian J, Zhou C, Zang C, Liu C, Wang X, Sun C

Cancer Management and Research 2018, 10:5869-5880

Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression

Sun H, Xi P, Sun Z, Wang Q, Zhu B, Zhou J, Jin H, Zheng W, Tang W, Cao H, Cao X

Cancer Management and Research 2018, 10:5725-5734

miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA

Yang X, Qiu J, Kang H, Wang Y, Qian J

Cancer Management and Research 2018, 10:5839-5853

Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities

Sirohi D, Smith SC, Agarwal N, Maughan BL

Research and Reports in Urology 2018, 10:205-217

Identification and validation of a four-miRNA(miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma

Xie MZ, Lv YF, Liu ZH, Zhang JY, Liang CY, Liao XL, Liang R, Lin Y, Li YQ

Cancer Management and Research 2018, 10:5759-5766

CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

Meng W, Wang J, Wang B, Liu F, Li M, Zhao Y, Zhang C, Li Q, Chen J, Zhang L, Tang Y, Ma J

Cancer Management and Research 2018, 10:5747-5758

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients

Zhu W, Li H, Yu Y, Chen J, Chen X, Ren F, Ren Z, Cui G

Cancer Management and Research 2018, 10:5735-5745

Severe neutropenia in a breastfed infant: a case report and discussion of the differential diagnosis

van den Broek L, van der Werff ten-Bosch J, Cortoos P, van Steijn S, van den Akker M

International Medical Case Reports Journal 2018, 11:333-337

Brain metastases in newly diagnosed colorectal cancer: a population-based study

Yang L, He W, Xie Q, Liu S, Kong P, Jiang C, Zhang B, Xia L

Cancer Management and Research 2018, 10:5649-5658

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia

Pei JS, Chang WS, Hsu PC, Chen CC, Cheng SP, Wang YC, Tsai CW, Shen TC, Bau DT

Cancer Management and Research 2018, 10:5677-5684

Comparison of gene expression in liver regeneration and hepatocellular carcinoma formation

Yin L, Wang Y, Guo X, Xu C, Yu G

Cancer Management and Research 2018, 10:5691-5708

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells

Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R

Cancer Management and Research 2018, 10:5709-5724

Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer

Yuan Z, Yuan Y, Han L, Qiu Y, Huang X, Gao F, Fan G, Zhang Y, Tang X, He X, Xu K, Yin P

International Journal of Nanomedicine 2018, 13:7533-7548

Safety and efficacy of microwave ablation for breast cancer thoracic metastases

Liu B, Wu ZJ, Mo H, He JL, Lin X, Guan J, Wei CY, Yuan ZC

Cancer Management and Research 2018, 10:5685-5689

Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs

Liu J, Zhang D, Lian S, Zheng J, Li B, Li T, Jia L

International Journal of Nanomedicine 2018, 13:7457-7472

IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab

Marisi G, Scarpi E, Passardi A, Nanni O, Pagan F, Valgiusti M, Casadei Gardini A, Neri LM, Frassineti GL, Amadori D, Ulivi P

Cancer Management and Research 2018, 10:5659-5666

The anticancer activity of genistein is increased in estrogen receptor beta 1-positive breast cancer cells

Jiang H, Fan JJ, Cheng L, Hu P, Liu RB

OncoTargets and Therapy 2018, 11:8153-8163

Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer

Sheng ML, Dong ZH, Xie YP

OncoTargets and Therapy 2018, 11:8143-8151

Follicle-stimulating hormone inhibits cervical cancer via NF-κB pathway

Shi X, Qiu S, Zhuang W, Wang C, Zhang S, Yuan N, Yuan F, Qiao Y

OncoTargets and Therapy 2018, 11:8107-8115

In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma

Zhu H, Ruan S, Jia F, Chu J, Zhu Y, Huang Y, Liu G

OncoTargets and Therapy 2018, 11:8117-8125

Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells

Tan Z, Zhang X, Kang T, Zhang L, Chen S

Drug Design, Development and Therapy 2018, 12:3913-3927

Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population

Semlali A, Parine NR, Al-Numair NS, Almutairi M, Hawsawi YM, Al Amri A, Aljebreen AM, Arafah M, Almadi MA, Azzam NA, Alharbi O, Alanazi MS

OncoTargets and Therapy 2018, 11:8127-8141

A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells

Liu G, Yin Q, Ji H, Wang Y, Liu H, Jiang L, Zhu F, Li B

Drug Design, Development and Therapy 2018, 12:3899-3912

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program

Mikkelsen EM, Thomsen MK, Tybjerg J, Friis-Hansen L, Andersen B, Jørgensen JC, Baatrup G, Njor SH, Mehnert F, Rasmussen M

Clinical Epidemiology 2018, 10:1649-1655

Peritumoral implantation of hydrogel-containing nanoparticles and losartan for enhanced nanoparticle penetration and antitumor effect

Shen H, Gao Q, Ye Q, Yang S, Wu Y, Huang Q, Wang X, Sun Z

International Journal of Nanomedicine 2018, 13:7409-7426

Carotid blowout syndrome: modern trends in management

Suárez C, Fernández-Alvarez V, Hamoir M, Mendenhall WM, Strojan P, Quer M, Silver CE, Rodrigo JP, Rinaldo A, Ferlito A

Cancer Management and Research 2018, 10:5617-5628

Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer

Wang D, Zhang X, Zhang Y, Wu Y, Guan X, Zhu W, Wang M, Qi C, Shen B

OncoTargets and Therapy 2018, 11:8083-8088

Lipocalin 2: a potential therapeutic target for breast cancer metastasis

Hu C, Yang K, Li M, Huang W, Zhang F, Wang H

OncoTargets and Therapy 2018, 11:8099-8106

High expression of TFEB is associated with aggressive clinical features in colorectal cancer

Liang J, Jia X, Wang K, Zhao N

OncoTargets and Therapy 2018, 11:8089-8098

Potential clinical application of lncRNAs in non-small cell lung cancer

Lu T, Wang Y, Chen D, Liu J, Jiao W

OncoTargets and Therapy 2018, 11:8045-8052

Patterns of regional nodal relapse after D2 lymphadenectomy in gastric cancer: rethinking the target volume

Yang W, Zhou M, Hu R, Li G, Wang Y, Shen L, Liang L, Yang J, Zhang Z

OncoTargets and Therapy 2018, 11:8015-8024

Prognostic value of TIGAR and LC3B protein expression in nasopharyngeal carcinoma

Wei M, Peng J, Wu P, Chen P, Yang H, Cui Y, Yang L

Cancer Management and Research 2018, 10:5605-5616

Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4

Gong T, Yu Y, Yang B, Lin M, Huang JW, Cheng B, Ji C

OncoTargets and Therapy 2018, 11:8063-8071

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma

Zhu Z, Zhang Y, Huang CS, Tang Y, Sun C, Ju W, He X

Cancer Management and Research 2018, 10:5559-5572

Lupeol inhibits growth and migration in two human colorectal cancer cell lines by suppression of Wnt–β-catenin pathway

Wang YH, Hong D, Qian YQ, Tu XZ, Wang KK, Yang XH, Shao SJ, Kong XL, Lou ZF, Jin LJ

OncoTargets and Therapy 2018, 11:7987-7999

Upregulation of centromere protein F is linked to aggressive prostate cancers

Göbel C, Özden C, Schroeder C, Hube-Magg C, Kluth M, Möller-Koop C, Neubauer E, Hinsch A, Jacobsen F, Simon R, Sauter G, Michl U, Pehrke D, Huland H, Graefen M, Schlomm T, Luebke AM

Cancer Management and Research 2018, 10:5491-5504

Matched-pair analysis of survival in the patients with T3 laryngeal squamous cell carcinoma treated with supracricoid partial laryngectomy or total laryngectomy

Xia X, Zhu YY, Diao WW, Zhu XL, Shi XH, Li WY, Gao ZQ, Li GJ, Chen XM

OncoTargets and Therapy 2018, 11:7947-7953

Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process

Gao H, Hao G, Sun Y, Li L, Wang Y

OncoTargets and Therapy 2018, 11:8001-8012

Species difference in paclitaxel disposition correlated with poor pharmacological efficacy translation from mice to humans

Li YF, Zhang C, Zhou S, He M, Zhang H, Chen N, Li F, Luan X, Pai M, Yuan H, Sun D, Li Y

Clinical Pharmacology: Advances and Applications 2018, 10:165-174

Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

Diem S, Fässler M, Hasan Ali O, Siano M, Niederer R, Berner F, Roux GA, Ackermann CJ, Schmid S, Güsewell S, Früh M, Flatz L

Cancer Management and Research 2018, 10:5537-5544

Identification of potential key genes associated with ovarian clear cell carcinoma

Xu Y, Shen K

Cancer Management and Research 2018, 10:5461-5470

A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment

Chen Y, Qu D, Fu R, Guo M, Qin Y, Guo J, Chen Y

International Journal of Nanomedicine 2018, 13:7275-7287

pH-triggered charge-reversal and redox-sensitive drug release polymer micelles co-deliver doxorubicin and triptolide for prostate tumor therapy

Xu C, Song R, Lu P, Chen JC, Zhou YQ, Shen G, Jiang MJ, Zhang W

International Journal of Nanomedicine 2018, 13:7229-7249

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study

Yuan H, Cao P, Li HL, Hu HT, Guo CY, Zhao Y, Yao QJ, Geng X

Cancer Management and Research 2018, 10:5545-5552

Impact of the anterior commissure involvement on the survival of early glottic cancer treated with cricohyoidoepiglottopexy: a retrospective study

Allegra E, Saita V, Azzolina A, De Natale M, Bianco MR, Modica DM, Garozzo A

Cancer Management and Research 2018, 10:5553-5558

Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo

Peng L, Huang YT, Chen J, Zhuang YX, Zhang F, Chen JY, Zhou L, Zhang DH

Cancer Management and Research 2018, 10:5471-5477

Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis

Wang Y, Wang P, Zheng X, Du X

OncoTargets and Therapy 2018, 11:7895-7908

The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study

Deng X, Lin D, Yu L, Xu X, Zhang N, Zhou H, Sheng H, Yin B, Lin F, Xu S, Li DD, Fang J, Lu X, Lin J

Cancer Management and Research 2018, 10:5515-5524

A Geant4-based Monte Carlo study of a benchtop multi-pinhole X-ray fluorescence computed tomography imaging

Deng L, Wei B, He P, Zhang Y, Feng P

International Journal of Nanomedicine 2018, 13:7207-7216

Nomogram application to predict overall and cancer-specific survival in osteosarcoma

Zheng W, Huang Y, Chen H, Wang N, Xiao W, Liang Y, Jiang X, Su W, Wen S

Cancer Management and Research 2018, 10:5439-5450

Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?

Kümmel S, Jackisch C, Müller V, Schneeweiss A, Klawitter S, Lux MP

Cancer Management and Research 2018, 10:5423-5431

TRIM37 targets AKT in the growth of lung cancer cells

Dong SM, Pang XQ, Sun HJ, Yuan CL, Mu CY, Zheng S

OncoTargets and Therapy 2018, 11:7935-7945

Feasibility single-arm study of a medical device containing Desmodium adscendens and Lithothamnium calcareum combined with chemotherapy in head and neck cancer patients

Imperatori L, Giardini D, Latini G, Migliori G, Blasi C, Bunkheila F, Breschi C, Mattioli R, Pelliccioni S, Laurino C, Vadala M, Palmieri B, Iannitti T

Cancer Management and Research 2018, 10:5433-5438

Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital, Northwest Ethiopia

Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT

Infection and Drug Resistance 2018, 11:2169-2178

Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line

Mokhtary P, Javan B, Sharbatkhari M, Soltani A, Erfani-Moghadam V

International Journal of Nanomedicine 2018, 13:7107-7121

Nitroxide-radicals–modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy

Xia L, Zhang C, Li M, Wang K, Wang Y, Xu P, Hu Y

International Journal of Nanomedicine 2018, 13:7123-7134

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib

Chen HF, Zhang QX, Zhu YC, Du KQ, Li XF, Wu LX, Wang WX, Xu CW

OncoTargets and Therapy 2018, 11:7821-7825

Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review

Zhang FH, Chen XW, Xi KH, Qiu ZQ, Wang YH, Gui Y, Hou Y, Chen KB, Zhang XB

OncoTargets and Therapy 2018, 11:7827-7840

EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression

Wang C, Li X, Zhang J, Ge Z, Chen H, Hu J

OncoTargets and Therapy 2018, 11:7853-7864

TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers

Du Y, Zhang W, Du B, Zang S, Wang X, Mao X, Hu Z

OncoTargets and Therapy 2018, 11:7841-7852

Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma

Yazarlou F, Mowla SJ, Kholghi Oskooei V, Motevaseli E, Farhady Tooli L, Afsharpad M, Nekoohesh L, Sanikhani NS, Ghafouri-Fard S, Modarressi MH

Cancer Management and Research 2018, 10:5373-5381

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification

Ke K, Chen G, Cai Z, Huang Y, Zhao B, Wang Y, Liao N, Liu X, Li Z, Liu J

Cancer Management and Research 2018, 10:5291-5302

Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study

Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, Xie X

Cancer Management and Research 2018, 10:5329-5338

Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study

Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ

Cancer Management and Research 2018, 10:5383-5394

A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma

Zou B, Liu X, Gong Y, Cai C, Li P, Xing S, Pokhrel B, Zhang B, Li J

Cancer Management and Research 2018, 10:5303-5311

Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis

Zhou X, Mo X, Qiu J, Zhao J, Wang S, Zhou C, Su Y, Lin Z, Ma H

Cancer Management and Research 2018, 10:5363-5372

Dietary vitamin B intake and the risk of esophageal cancer: a meta-analysis

Ma JL, Zhao Y, Guo CY, Hu HT, Zheng L, Zhao EJ, Li HL

Cancer Management and Research 2018, 10:5395-5410

Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening

Atatreh N, Ghattas MA, Bardaweel SK, Al Rawashdeh S, Al Sorkhy M

Drug Design, Development and Therapy 2018, 12:3741-3752

Inhibition of long non-coding RNA HOTAIR enhances radiosensitivity via regulating autophagy in pancreatic cancer

Wu CL, Yang L, Qi X, Wang TF, Li M, Xu K

Cancer Management and Research 2018, 10:5261-5271

Burden of cancer pain in developing countries: a narrative literature review

Li Z, Aninditha T, Griene B, Francis J, Renato P, Serrie A, Umareddy I, Boisseau S, Hadjiat Y

ClinicoEconomics and Outcomes Research 2018, 10:675-691

MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells

Meng D, Lei M, Han Y, Zhao D, Zhang X, Yang Y, Liu R

OncoTargets and Therapy 2018, 11:7733-7743

PTPRF as a novel tumor suppressor through deactivation of ERK1/2 signaling in gastric adenocarcinoma

Tian X, Yang C, Yang L, Sun Q, Liu N

OncoTargets and Therapy 2018, 11:7795-7803

Decreased expression of peroxiredoxin1 inhibits proliferation, invasion, and metastasis of ovarian cancer cell

Zheng MJ, Wang J, Wang HM, Gao LL, Li X, Zhang WC, Gou R, Guo Q, Nie X, Liu J, Lin B

OncoTargets and Therapy 2018, 11:7745-7761

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib

Pearre DC, Tewari KS

Therapeutics and Clinical Risk Management 2018, 14:2189-2201

Reconstruction of feminine identity: the strategies of women with breast cancer to cope with body image altered

Zeighami Mohammadi S, Mohammad Khan Kermanshahi S, Vanaki Z

International Journal of Women's Health 2018, 10:689-697

Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME

Rubinkiewicz M, Nowakowski M, Wierdak M, Mizera M, Dembiński M, Pisarska M, Major P, Małczak P, Budzyński A, Pędziwiatr M

Cancer Management and Research 2018, 10:5239-5245

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer

Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K

Cancer Management and Research 2018, 10:5283-5290

Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma

Zhou YL, Zheng C, Chen YT, Chen XM

OncoTargets and Therapy 2018, 11:7725-7731

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients

Matevska-Geshkovska N, Staninova-Stojovska M, Kapedanovska-Nestorovska A, Petrushevska-Angelovska N, Panovski M, Grozdanovska B, Mitreski N, Dimovski A

Pharmacogenomics and Personalized Medicine 2018, 11:193-203

Options of medical treatment and laryngeal function preservation in elderly patients with medial wall pyriform sinus cancer

Wang Q, Liu Y, Wu K, Zhao Y, Gao C, Tong B, Zhang M

OncoTargets and Therapy 2018, 11:7441-7446

Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation

Regenthal R, Voskanian M, Baumann F, Teichert J, Brätter C, Aigner A, Abraham G

Drug Design, Development and Therapy 2018, 12:3653-3664

Clinicopathological analysis of PD-L2 expression in colorectal cancer

Guo PD, Sun ZW, Lai HJ, Yang J, Wu PP, Guo YD, Sun J

OncoTargets and Therapy 2018, 11:7635-7642

Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan

Huang CY, Chang WS, Tsai CW, Hsia TC, Shen TC, Bau DT, Shui HA

Cancer Management and Research 2018, 10:5199-5207

Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study

Ou S, Xu R, Li K, Chen Y, Kong Y, Liu H, Li J, Ouyang Y, Yu X

Cancer Management and Research 2018, 10:5227-5237

ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer

Wei JW, Huang R, Guo SP, Zhang XH, Xi SY, Wang QX, Chang H, Wang XH, Xiao WW, Zeng ZF, Gao YH

Cancer Management and Research 2018, 10:5219-5225

Cytotoxic effect of Drimia maritima bulb extract and induction of mitochondrial apoptotic signaling in human breast cancer cells, MCF-7 and MDA-MB-468

Hamzeloo-Moghadam M, Aghaei M, Abdolmohammadi MH, Khalaj A, Fallahian F

OncoTargets and Therapy 2018, 11:7669-7677

A qualitative study on the attitudes of patients with gastrointestinal cancer toward being informed of the truth

Yang F, Zhang Q, Kong W, Shen H, Lu J, Ge X, Zhuang Y

Patient Preference and Adherence 2018, 12:2283-2290

Eliciting vulnerable patients’ preferences regarding colorectal cancer screening: a systematic review

Lee SJ, O'Leary MC, Umble KE, Wheeler SB

Patient Preference and Adherence 2018, 12:2267-2282

Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer

Yildiz T, Gu R, Zauscher S, Betancourt T

International Journal of Nanomedicine 2018, 13:6961-6986

Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

Phillips CJ, Wisdom AJ, McKinnon RA, Woodman RJ, Gordon DL

Infection and Drug Resistance 2018, 11:2081-2094

Biosafety evaluation of Janus Fe3O4-TiO2 nanoparticles in Sprague Dawley rats after intravenous injection

Su H, Song X, Li J, Iqbal MZ, Fiati Kenston SS, Li Z, Wu A, Ding M, Zhao J

International Journal of Nanomedicine 2018, 13:6987-7001

CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer

Gan Y, Li Y, Li T, Shu G, Yin G

Cancer Management and Research 2018, 10:5113-5124

Genetic variants in lncRNA HOTAIR are associated with lung cancer susceptibility in a Chinese Han population in China: a case–control study

Li H, Yang Z, Li J, Lv X, Gao M, Bi Y, Zhang Z, Wang S, Li S, Li N, Cui Z, Zhou B, Yin Z

Cancer Management and Research 2018, 10:5209-5218

A meta-analysis of nivolumab for the treatment of advanced non-small-cell lung cancer

Chen S, Hu B, Li H

OncoTargets and Therapy 2018, 11:7691-7697

Acyl-CoA dehydrogenase long chain expression is associated with esophageal squamous cell carcinoma progression and poor prognosis

Yu DL, Li HW, Wang Y, Li CQ, You D, Jiang L, Song YP, Li XH

OncoTargets and Therapy 2018, 11:7643-7653

Laparoscopic right hemicolectomy oriented by superior mesenteric artery for right colon cancer: efficacy evaluation with a match-controlled analysis

Dai W, Zhang J, Xiong W, Xu J, Cai S, Tan M, He Y, Song W, Yuan Y

Cancer Management and Research 2018, 10:5157-5170

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study

Wu F, Zhang Y, Yang Y, Lu X, Fang Z, Huang J, Kong L, Chen J, Ning Y, Li X, Wu K

Neuropsychiatric Disease and Treatment 2018, 14:2889-2904

Protein tyrosine phosphatase L1 inhibits high-grade serous ovarian carcinoma progression by targeting IκBα

Wang Y, Li M, Huang T, Li J

OncoTargets and Therapy 2018, 11:7603-7612

Epidural dexmedetomidine infusion for perioperative analgesia in patients undergoing abdominal cancer surgery: randomized trial

Hetta DF, Fares KM, Abedalmohsen AM, Abdel-Wahab AH, Abo Elfadl GM, Ali WN

Journal of Pain Research 2018, 11:2675-2685

MicroRNA-588 regulates invasion, migration and epithelial–mesenchymal transition via targeting EIF5A2 pathway in gastric cancer

Zhou X, Xu M, Guo Y, Ye L, Long L, Wang H, Tan P, Xu M

Cancer Management and Research 2018, 10:5187-5197

MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells

Wang C, Su K, Zhang Y, Zhang W, Chu D, Zhao Q, Guo R

Cancer Management and Research 2018, 10:5171-5185

The fluctuating incidence, improved survival of patients with breast cancer, and disparities by age, race, and socioeconomic status by decade, 1981–2010

Lu G, Li J, Wang S, Pu J, Sun H, Wei Z, Ma Y, Wang J, Ma H

Cancer Management and Research 2018, 10:4899-4914

Knockdown of PRL-3 increases mitochondrial superoxide anion production through transcriptional regulation of RAP1

Yang Y, Lian S, Meng L, Tian Z, Feng Q, Wang Y, Wang P, Qu L, Shou C

Cancer Management and Research 2018, 10:5071-5081

Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer

Lu Y, Jiang W, Wu X, Huang S, Huang Z, Shi Y, Dai Q, Chen J, Ren F, Gao S

International Journal of Nanomedicine 2018, 13:6913-6927

Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells

Zhand S, Hosseini SM, Tabarraei A, Saeidi M, Saghaeian Jazi M, Kalani MR, Moradi A

Oncolytic Virotherapy 2018, 7:95-105

Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma

Gao H, Li L, Xiao M, Guo Y, Shen Y, Cheng L, Tang M

Cancer Management and Research 2018, 10:5083-5089

Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer

Xue C, He Y, Hu Q, Yu Y, Chen X, Chen J, Ren F, Li J, Ren Z, Cui G, Sun R

Cancer Management and Research 2018, 10:5101-5112

Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy

Xia Y, Chen Y, Hua L, Zhao M, Xu T, Wang C, Li Y, Zhu B

International Journal of Nanomedicine 2018, 13:6929-6939

Behavior change techniques for increasing physical activity in cancer survivors: a systematic review and meta-analysis of randomized controlled trials

Finne E, Glausch M, Exner AK, Sauzet O, Stölzel F, Seidel N

Cancer Management and Research 2018, 10:5125-5143

Influence of the type of emphysema in the relationship between COPD and lung cancer

Mouronte-Roibás C, Fernández-Villar A, Ruano-Raviña A, Ramos-Hernández C, Tilve-Gómez A, Rodríguez-Fernández P, Caldera Díaz AC, Vázquez-Noguerol MG, Fernández-García S, Leiro-Fernández V

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3563-3570

Practical management of opioid rotation and equianalgesia

Treillet E, Laurent S, Hadjiat Y

Journal of Pain Research 2018, 11:2587-2601

Transfer of rosuvastatin into breast milk: liquid chromatography–mass spectrometry methodology and clinical recommendations

Lwin EMP, Leggett C, Ritchie U, Gerber C, Song Y, Hague W, Turner S, Upton R, Garg S

Drug Design, Development and Therapy 2018, 12:3645-3651

Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression

Tian W, Hao S, Gao B, Jiang Y, Zhang X, Zhang S, Guo L, Zhao J, Zhang G, Chen Y, Li Z, Luo D

Drug Design, Development and Therapy 2018, 12:3563-3571

BMP-2 inhibits lung metastasis of osteosarcoma: an early investigation using an orthotopic model

Xiong Q, Wang X, Wang L, Huang Y, Tian X, Fan Y, Lin CY

OncoTargets and Therapy 2018, 11:7543-7553

Sirt3 enhances glioma cell viability by stabilizing Ku70–BAX interaction

Luo K, Huang W, Tang S

OncoTargets and Therapy 2018, 11:7559-7567

Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes

Cuccia F, Mortellaro G, Serretta V, Valenti V, Tripoli A, Gueci M, Luca N, Lo Casto A, Ferrera G

Cancer Management and Research 2018, 10:5053-5060

Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma

Li J, Huang SL, Zhou Z, Lin W, Chen S, Chen M, Ye Y

Cancer Management and Research 2018, 10:4945-4957

pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery

Shi Ms, Zhao X, Zhang J, Pan S, Yang C, Wei Y, Hu H, Qiao M, Chen D, Zhao X

International Journal of Nanomedicine 2018, 13:6885-6902

Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy

Wang H, Zhang L, Si X, Zhang X, Wang M

OncoTargets and Therapy 2018, 11:7513-7519

Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene

Sun X, Kong L, Li B, Zhang Y, Yang H

Cancer Management and Research 2018, 10:5019-5026

Celecoxib in breast cancer prevention and therapy

Li J, Hao Q, Cao W, Vadgama JV, Wu Y

Cancer Management and Research 2018, 10:4653-4667

Silicosis and lung cancer: current perspectives

Sato T, Shimosato T, Klinman DM

Lung Cancer: Targets and Therapy 2018, 9:91-101

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis

Wu P, Wang PL, Ma B, Yin SC, Tan YE, Hou WB, Wang ZN, Xu HM, Zhu Z

Cancer Management and Research 2018, 10:4759-4771

Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors

Rahimzadeh P, Imani F, Nafissi N, Ebrahimi B, Faiz SHR

Cancer Management and Research 2018, 10:4831-4837

Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis

Li L, Cao Y, Zhou H, Li Y, He B, Zhou X, Nie Z, Liang L, Liu Y, Ye L

OncoTargets and Therapy 2018, 11:7471-7481

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation

Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A

Lung Cancer: Targets and Therapy 2018, 9:85-90

Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases

Wang Y, Yu M, Yang JX, Cao DY, Shen K, Lang JH

Cancer Management and Research 2018, 10:4915-4928

Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer

Ma YT, Xing XF, Dong B, Cheng XJ, Guo T, Du H, Wen XZ, Ji JF

Cancer Management and Research 2018, 10:4969-4980

Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study

Lin J, Zhang W, Huang Y, Chen W, Wu R, Chen X, Lou N, Wang P

Cancer Management and Research 2018, 10:4935-4944

Improving risk prediction for pancreatic cancer in symptomatic patients: a Saudi Arabian study

Ahmed AE, Alzahrani FS, Gharawi AM, Alammary SA, Almijmaj FH, Alhusayni FM, McClish DK, Al-Jahdali H, Al Olayan AA, Jazieh AR

Cancer Management and Research 2018, 10:4981-4986

Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report

Xie S, Wu Z, Zhou L, Liang Y, Wang X, Niu L, Xu K, Chen J, Zhang M

OncoTargets and Therapy 2018, 11:7345-7352

The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China

Liu Y, Qian L, Yang J, Huang H, Feng J, Li X, Bian T, Ke H, Liu J, Zhang J

OncoTargets and Therapy 2018, 11:7459-7469

Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA -2 study)

Lund L, Nisen H, Järvinen P, Fovaeus M, Gudmundsson E, Kromann-Andersen B, Ljungberg B, Nilsen F, Sundqvist P, Clark PE, Beisland C

Research and Reports in Urology 2018, 10:181-187

Long noncoding RNA UCA1 promotes the proliferation, invasion, and migration of nasopharyngeal carcinoma cells via modulation of miR-145

Wu J, Du M, Zhang Q, Zhang W, Fan Y, Yin L, Fei Q, Jiang X, Chen W, Zhu H, Yan P, He X, Bian X

OncoTargets and Therapy 2018, 11:7483-7492

Conceptualizing age-appropriate care for teenagers and young adults with cancer: a qualitative mixed-methods study

Lea S, Taylor RM, Martins A, Fern LA, Whelan JS, Gibson F

Adolescent Health, Medicine and Therapeutics 2018, 9:149-166

Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer

Qiu W, Chen R, Chen X, Zhang H, Song L, Cui W, Zhang J, Ye D, Zhang Y, Wang Z

International Journal of Nanomedicine 2018, 13:6809-6827

Tramadol: a valuable treatment for pain in Southeast Asian countries

Vijayan R, Afshan G, Bashir K, Cardosa M, Chadha M, Chaudakshetrin P, Hla KM, Joshi M, Javier FO, Kayani AG, Musba AT, Nimmaanrat S, Pantjawibowo D, Que JC, Vijayanand P

Journal of Pain Research 2018, 11:2567-2575

Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery

Mosk CA, van Vugt JLA, de Jonge H, Witjes CDM, Buettner S, Ijzermans JNM, van der Laan L

Clinical Interventions in Aging 2018, 13:2097-2106

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions

Tucci M, Zichi C, Buttigliero C, Vignani F, Scagliotti GV, Di Maio M

OncoTargets and Therapy 2018, 11:7353-7368

Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma

Tian J, Liu X, Liu X, Jing P, Sa N, Wang H, Xu W

OncoTargets and Therapy 2018, 11:7395-7405

Contribution of dysregulated circRNA_100876 to proliferation and metastasis of esophageal squamous cell carcinoma

Cao S, Chen G, Yan L, Li L, Huang X

OncoTargets and Therapy 2018, 11:7385-7394

Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer

Ren K, Yin Y, He F, Shao Y, Wang S

Cancer Management and Research 2018, 10:4891-4898

Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma

Qi N, Zhang J, Chen Y, Wen R, Li H

Cancer Management and Research 2018, 10:4929-4933

Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy

Yun T, Liu Y, Yi S, Jia Q, Liu Y, Zhou J

International Journal of Nanomedicine 2018, 13:6647-6659

Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer

Yu H, Wei W, Cao W, Zhan Z, Yan L, Wu K, Xie D, Cai B, Xie Y, Xiao Q

OncoTargets and Therapy 2018, 11:7429-7440

Research progress on GP73 in malignant tumors

Liang R, Liu Z, Piao X, Zuo M, Zhang J, Liu Z, Li Y, Lin Y

OncoTargets and Therapy 2018, 11:7417-7421

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer

Salman P, Panay S, Fernández R, Mahave M, Soza-Ried C

OncoTargets and Therapy 2018, 11:7295-7300

Glutathione S-transferase π: a potential role in antitumor therapy

Dong S, Sha H, Xu X, Hu T, Lou R, Li H, Wu J, Dan C, Feng J

Drug Design, Development and Therapy 2018, 12:3535-3547

Radiation therapy’s efficacy on tongue cancer: a population-based survival analysis

Zhu Y, Zhou C, He Q

OncoTargets and Therapy 2018, 11:7271-7276

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

Rodallec A, Sicard G, Giacometti S, Carré M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R

International Journal of Nanomedicine 2018, 13:6677-6688

Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients

Liu Z, Wu L, Cao J, Yang Z, Zhou C, Cao L, Wu H, Shen H, Jin M, Zhang Y, Mao X, Xiang J, Ma K, Li B, Zhang T, Hu Y

OncoTargets and Therapy 2018, 11:7323-7331

Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles

Winter A, Kowald T, Paulo TS, Goos P, Engels S, Gerullis H, Schiffmann J, Chavan A, Wawroschek F

International Journal of Nanomedicine 2018, 13:6689-6698

pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation

Kim CH, Sa CK, Goh MS, Lee ES, Kang TH, Yoon HY, Battogtokh G, Ko YT, Choi YW

International Journal of Nanomedicine 2018, 13:6661-6675

Bilateral salpingectomy versus bilateral partial salpingectomy during cesarean delivery

Duncan JR, Jones HL, Hoffer SO, Schenone MH, Mari G

International Journal of Women's Health 2018, 10:649-653

Identification of chemoresistance-associated miRNAs in breast cancer

Lou W, Liu J, Ding B, Xu L, Fan W

Cancer Management and Research 2018, 10:4747-4757

Quality of life worsened the most severely in patients immediately after intensity-modulated radiation therapy for prostate cancer

Nakai Y, Tanaka N, Anai S, Miyake M, Asakawa I, Morizawa Y, Hori S, Torimoto K, Fujii T, Hasegawa M, Fujimoto K

Research and Reports in Urology 2018, 10:169-180

Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition

Gao YJ, Liu DL, Li S, Yuan GF, Li L, Zhu HY, Cao GY

OncoTargets and Therapy 2018, 11:7333-7343

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer

Zhu X, Li F, Shi D, Ju X, Cao Y, Shen Y, Cao F, Qing S, Fang F, Jia Z, Zhang H

Cancer Management and Research 2018, 10:4805-4815

MCL-1 inhibition in cancer treatment

Xiang W, Yang CY, Bai L

OncoTargets and Therapy 2018, 11:7301-7314

Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study

Guo Y, Cai K, Mao S, Zhang J, Wang L, Zhang Z, Liu M, Zhang W, Wu Y, Yan Y, Yao X

Cancer Management and Research 2018, 10:4789-4804

Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways

Fan L, He Z, Head SA, Zhou Y, Lu T, Feng X, Zhang X, Zhang M, Dang Y, Jiang X, Wang M

Cancer Management and Research 2018, 10:4817-4829

Expression of chemerin correlates with a poor prognosis in female breast cancer patients

El-Sagheer G, Gayyed M, Ahmad A, Abd El-Fatah A, Mohamed M

Breast Cancer: Targets and Therapy 2018, 10:169-176

Hypoxia-activated prodrugs and redox-responsive nanocarriers

Zeng Y, Ma J, Zhan Y, Xu X, Zeng Q, Liang J, Chen X

International Journal of Nanomedicine 2018, 13:6551-6574

Cognitive function and 3-year mortality in the very elderly Chinese population with chronic kidney disease

Bai K, Pan Y, Lu F, Zhao Y, Wang F, Zhang L

Clinical Interventions in Aging 2018, 13:2055-2060

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ

Wang LP, Yang XC, Li D, Liang ZJ, Chen YB, Ma GF, Wang YH, Li YX, Liang Y, Niu HT

OncoTargets and Therapy 2018, 11:7229-7243

Impact of tumor dimensions and lymph node density on the survival of patients with hypopharyngeal squamous cell carcinoma

Ye LL, Rao J, Fan XW, Ji QH, Hu CS, Ying HM

Cancer Management and Research 2018, 10:4679-4688

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer

Wang J, Sahengbieke S, Xu X, Zhang L, Xu X, Sun L, Deng Q, Wang D, Chen D, Pan Y, Liu Z, Yu S

OncoTargets and Therapy 2018, 11:7155-7168

miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins

Sun Y, Hu B, Wang Y, Li Z, Wu J, Yang Y, Wei Y, Peng X, Chen H, Chen RQ, Jiang P, Fang S, Yu Z, Guo L

Cancer Management and Research 2018, 10:4735-4745

The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin

Wang X, Tian J, Jiao X, Geng J, Wang R, Liu N, Gao X, Griffin N, Gao Y, Shan F

Cancer Management and Research 2018, 10:4773-4787

Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection

Luo P, Cai W, Yang L, Chen S, Wu Z, Chen Y, Zhang R, Shi Y, Yan W, Wang C

Cancer Management and Research 2018, 10:4727-4734

The impact of prophylactic dexamethasone on postoperative sore throat: an updated systematic review and meta-analysis

Jiang Y, Chen R, Xu S, Li J, Yu F, Kong L, Sun Y, Ye Y, Li Y, Yu M, Wu J

Journal of Pain Research 2018, 11:2463-2475

Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic review

Ren Q, Li B, Liu M, Hu Z, Wang Y

OncoTargets and Therapy 2018, 11:7169-7178

Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure

Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ

ClinicoEconomics and Outcomes Research 2018, 10:629-641

Prevalence of functional dependence in Chinese centenarians and its relationship with serum vitamin D status

Yao Y, Fu S, Shi Q, Zhang H, Zhu Q, Zhang F, Luan F, Zhao Y, He Y

Clinical Interventions in Aging 2018, 13:2045-2053

MicroRNA-195: a review of its role in cancers

Yu W, Liang X, Li X, Zhang Y, Sun Z, Liu Y, Wang J

OncoTargets and Therapy 2018, 11:7109-7123

Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis

Zhang Y, Wang L, Lin S, Wang R

Cancer Management and Research 2018, 10:4695-4708

Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers

Montavon Sartorius C, Mirza U, Schötzau A, Mackay G, Fink D, Hacker NF, Heinzelmann-Schwarz V

Cancer Management and Research 2018, 10:4709-4718

Overexpression of APC11 predicts worse survival in lung adenocarcinoma

Zhou J, Zhang S, Fu G, He Z, Xu Y, Ye W, Chen Z

OncoTargets and Therapy 2018, 11:7125-7132

Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma

Zhang DY, Liu Z, Lu Z, Sun WL, Ma X, Zhang P, Wu BQ, Cui PY

OncoTargets and Therapy 2018, 11:7133-7142

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

Kakadia S, Yarlagadda N, Awad R, Kundranda M, Niu J, Naraev B, Mina L, Dragovich T, Gimbel M, Mahmoud F

OncoTargets and Therapy 2018, 11:7095-7107

Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration

Ciccarelli O, Colson A, De Saeger C, Reding R, Sempoux C, Leclercq IA, Stärkel P

OncoTargets and Therapy 2018, 11:7143-7153

The role of biosimilars in value-based oncology care

Patel KB, Arantes Jr LH, Tang WY, Fung S

Cancer Management and Research 2018, 10:4591-4602

Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy

Wu J, Tang Y, Liang X

OncoTargets and Therapy 2018, 11:6901-6909

Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway

Khophai S, Thanee M, Techasen A, Namwat N, Klanrit P, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Loilome W

OncoTargets and Therapy 2018, 11:7019-7029

Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles

Yang C, Hwang HH, Jeong S, Seo D, Jeong Y, Lee DY, Lee K

International Journal of Nanomedicine 2018, 13:6517-6530

Biomimetic quantum dot-labeled B16F10 murine melanoma cells as a tool to monitor early steps of lung metastasis by in vivo imaging

Díaz-García VM, Guerrero S, Díaz-Valdivia N, Lobos-González L, Kogan M, Pérez-Donoso JM, Quest AFG

International Journal of Nanomedicine 2018, 13:6391-6412

Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy

Zhang ZN, Luo C, Xu B, Song HF, Ma BL, Zhang Q

Cancer Management and Research 2018, 10:4671-4677

DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1α expression through the PI3K-AKT pathway

Zheng H, Zhou C, Lu X, Liu Q, Liu M, Chen G, Chen W, Wang S, Qiu Y

Cancer Management and Research 2018, 10:4615-4629

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics

de Vries S, Schaapveld M, Kardaun JWPF, de Bruin KH, Krol ADG, Lugtenburg PJ, Jacobse JN, Aleman BMP, van Leeuwen FE

Clinical Epidemiology 2018, 10:1523-1531

TIM-3, a promising target for cancer immunotherapy

He Y, Cao J, Zhao C, Li X, Zhou C, Hirsch FR

OncoTargets and Therapy 2018, 11:7005-7009

Research progress of the clinicopathologic features of lung adenosquamous carcinoma

Wang J, Wang Y, Tong M, Pan H, Li D

OncoTargets and Therapy 2018, 11:7011-7017

Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia

Otremba B, Hielscher C, Petersen V, Petrik C

Patient Preference and Adherence 2018, 12:2179-2186

NFATC2 is a novel therapeutic target for colorectal cancer stem cells

Lang T, Ding X, Kong L, Zhou X, Zhang Z, Ju HX, Ding S

OncoTargets and Therapy 2018, 11:6911-6924

Advances in antitumor effects of NSAIDs

Zhang Z, Chen FL, Shang L

Cancer Management and Research 2018, 10:4631-4640

Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population

Yang S, Chen J, Yu Y, Li D, Huang M, Yuan L, Yin G

Cancer Management and Research 2018, 10:4641-4652

CAV3.1 knockdown suppresses cell proliferation, migration and invasion of prostate cancer cells by inhibiting AKT

Hu SB, Li L, Huang W, Liu J, Lan G, Yu S, Peng L, Xie X, Yang L, Nian Y, Wang Y

Cancer Management and Research 2018, 10:4603-4614

Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer

Liao P, Li W, Liu RZ, Teer JK, Xu BB, Zhang W, Li X, Mcleod HL, He YJ

OncoTargets and Therapy 2018, 11:6969-6980

Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus

Peng J, Wang S, Fan W, Li S, Wu Y, Mou X, Wang J, Tong X

OncoTargets and Therapy 2018, 11:6887-6900

Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer

Shi H, Huang H, Pu J, Shi DC, Ning Y, Dong Y, Han Y, Zarogoulidis P, Bai C

OncoTargets and Therapy 2018, 11:6995-7003

Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients

Lozano C, Córdova C, Marchant I, Zúñiga R, Ochova P, Ramírez-Barrantes R, González-Arriagada WA, Rodriguez B, Olivero P

Breast Cancer: Targets and Therapy 2018, 10:161-168

Cancer drug therapy and stochastic modeling of “nano-motors”

Sherin L, Farwa S, Sohail A, Li Z, Bég OA

International Journal of Nanomedicine 2018, 13:6429-6440

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer

Zeng L, Li Y, Xiao L, Xiong Y, Liu L, Jiang W, Heng J, Qu J, Yang N, Zhang Y

OncoTargets and Therapy 2018, 11:6937-6945

MicroRNA-365 suppresses cell growth and invasion in esophageal squamous cell carcinoma by modulating phosphoserine aminotransferase 1

Sun C, Zhang X, Chen Y, Jia Q, Yang J, Shu Y

Cancer Management and Research 2018, 10:4581-4590

SMAGP a novel biomarker of cervical cancer development and progression

Jia Y, Li H, Liu G, Song F

OncoTargets and Therapy 2018, 11:6925-6935

Application of fluorescein sodium in breast cancer brain-metastasis surgery

Xiao S, Zhang J, Zhu Z, Li Y, Zhong W, Chen J, Pan Z, Xia H

Cancer Management and Research 2018, 10:4325-4331

One type of duplex appendix: horseshoe appendix

Liu J, Dong C, Wang H, Sun D, Liang R, Gao Z, Wang L

Therapeutics and Clinical Risk Management 2018, 14:1987-1992

Photothermal exposure of polydopamine-coated branched Au–Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells

Zhao X, Qi T, Kong C, Hao M, Wang Y, Li J, Liu B, Gao Y, Jiang J

International Journal of Nanomedicine 2018, 13:6413-6428

Positive predictive value of ICD-10 diagnosis codes for brain abscess in the Danish National Patient Registry

Bodilsen J, Dalager-Pedersen M, Kjærgaard N, van de Beek D, Brouwer MC, Nielsen H

Clinical Epidemiology 2018, 10:1503-1508

The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT/β-catenin pathway

Liu S, Liu Y, Lu Q, Zhou X, Chen L, Liang W

OncoTargets and Therapy 2018, 11:6845-6851

Moderating effects of sleep duration on diabetes risk among cancer survivors: analysis of the National Health Interview Survey in the USA

Seixas AA, Gyamfi L, Newsome V, Ranger-Murdock G, Butler M, Rosenthal DM, Zizi F, Youssef I, McFarlane SI, Jean-Louis G

Cancer Management and Research 2018, 10:4575-4580

Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution

Chen SW, Zhang Q, Guo ZM, Chen WK, Liu WW, Chen YF, Li QL, Liu XK, Li H, Ou-Yang D, Chen WC, Fu XY, Wang XD, Yang AK, Bei JX, Song M

Cancer Management and Research 2018, 10:4523-4535

Rasip1 is a RUNX1 target gene and promotes migration of NSCLC cells

Chen Y, Zhang L, Liu L, Sun S, Zhao X, Wang Y, Zhang Y, Du J, Gu L

Cancer Management and Research 2018, 10:4537-4552

Predictive biomarkers for tumor immune checkpoint blockade

Tong M, Wang J, He W, Wang Y, Pan H, Li D, Zhang H

Cancer Management and Research 2018, 10:4501-4507

Clinicopathological characteristics and survival outcomes of bladder neuroendocrine carcinomas: a population-based study

Niu Q, Lu Y, Xu S, Shi Q, Guo B, Guo Z, Huang T, Wu Y, Yu J

Cancer Management and Research 2018, 10:4479-4489

Familial risks of second primary cancers and mortality in ovarian cancer patients

Zheng G, Chattopadhyay S, Försti A, Sundquist K, Hemminki K

Clinical Epidemiology 2018, 10:1457-1466

Confirmed value of shear wave elastography for ultrasound characterization of breast masses using a conservative approach in Chinese women: a large-size prospective multicenter trial

Lin X, Chang C, Wu CJ, Chen Q, Peng YL, Luo BM, Tang LN, Li J, Zheng JH, Zhou RH, Cui GH, Li A, Wang XM, Qian LX, Zhang JX, Wen CY, Gay J, Zhang HL, Li AH, Chen YL

Cancer Management and Research 2018, 10:4447-4458

Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia

Kobayashi D, Shindo Y, Ito R, Iwaki M, Okumura J, Sakakibara T, Yamaguchi I, Yagi T, Ogasawara T, Sugino Y, Taniguchi H, Saito H, Saka H, Kawamura T, Hasegawa Y

Infection and Drug Resistance 2018, 11:1703-1713

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sanjurjo Sáez M, Martín M, López-Fernández LA

Cancer Management and Research 2018, 10:4517-4522

Primary hepatocellular carcinoma in a patient with history of treated breast cancer: a case report with challenging diagnosis and treatment

Kosmidis C, Varsamis N, Anthimidis G, Baka S, Valoukas D, Koletsa T, Zarampouka K, Koimtzis G, Georgakoudi E, Zarogoulidis P, Efthymiadis C

International Journal of General Medicine 2018, 11:399-403

SATB1 siRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells

Yang F, Zheng Z, Zheng L, Qin J, Li H, Xue X, Gao J, Fang G

OncoTargets and Therapy 2018, 11:6811-6825

Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells

O'Day EM, Idos GE, Hill C, Chen JW, Wagner G

OncoTargets and Therapy 2018, 11:6827-6838

Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study

Zhang WW, Wu SG, Ling YH, Sun JY, Long ZQ, Hua X, Dong Y, Li FY, He ZY, Lin HX

Cancer Management and Research 2018, 10:4509-4515

Metastatic malignancies and the effect on arterial stiffness and blood pressure levels: the possible role of chemotherapy

Res E, Kyvelou SM, Vlachopoulos C, Manousou K, Tousoulis D, Stefanadis C, Pektasides D

OncoTargets and Therapy 2018, 11:6785-6793

Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy

Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, You Y, Wang S, Chen X, Sui X, Xie T

International Journal of Nanomedicine 2018, 13:6279-6296

Inhibition of sialidase activity as a therapeutic approach

Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN

Drug Design, Development and Therapy 2018, 12:3431-3437

Efficacy and safety of chemopreventive agents on colorectal cancer incidence and mortality: systematic review and network meta-analysis

Veettil SK, Jinatongthai P, Nathisuwan S, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Reid CM, Chaiyakunapruk N

Clinical Epidemiology 2018, 10:1433-1445

Whole-body vibration training – better care for COPD patients: a systematic review and meta-analysis

Zhou J, Pang L, Chen N, Wang Z, Wang C, Hai Y, Lyu M, Lai H, Lin F

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3243-3254

Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial

Qiu H, Ren W, Yang Y, Zhu X, Mao G, Mao S, Lin Y, Shen S, Li C, Shi H, Jiang S, He J, Zhao K, Fu Y, Hu X, Gu Y, Wang K, Guo X, He J

Neuropsychiatric Disease and Treatment 2018, 14:2665-2673

YAP regulates ALDH1A1 expression and stem cell property of bladder cancer cells

Zhao AY, Dai YJ, Lian JF, Huang Y, Lin JG, Dai YB, Xu TW

OncoTargets and Therapy 2018, 11:6657-6663

Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer

Du X, Zhang L, Zhang D, Yang L, Fan Y, Dong S

OncoTargets and Therapy 2018, 11:6767-6775

Prognostic values of HE4 expression in patients with cancer: a meta-analysis

Dai C, Zheng Y, Li Y, Tian T, Wang M, Xu P, Deng Y, Hao Q, Wu Y, Zhai Z, Dai Z, Lyu J

Cancer Management and Research 2018, 10:4491-4500

MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial–mesenchymal transition in lung cancer cells

Pan B, Han H, Wu L, Xiong Y, Zhang J, Dong B, Yang Y, Chen J

OncoTargets and Therapy 2018, 11:6741-6756

SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis

Zhang X, Zhang P, Shao M, Zang X, Zhang J, Mao F, Qian H, Xu W

Cancer Management and Research 2018, 10:4459-4470

Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma

Zhu Z, Xu L, Zhuang L, Ning Z, Zhang C, Yan X, Lin J, Shen Y, Wang P, Meng Z

OncoTargets and Therapy 2018, 11:6731-6740

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

Chen Y, Zeng Q, Liu X, Fu J, Zeng Z, Zhao Z, Liu Z, Bai W, Dong Z, Liu H, Lu X, Zhu Y, Lu Y

Cancer Management and Research 2018, 10:4421-4438

Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression

Wang L, Du L, Duan W, Yan S, Xie Y, Wang C

OncoTargets and Therapy 2018, 11:6757-6766

How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma

Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA

Patient Preference and Adherence 2018, 12:2103-2110

Association between PSA and age in Macuxi ethnic population of the Brazilian Amazon forest region

de Lima Junior MM, Filho SSJ, Tobias-Machado M

Research and Reports in Urology 2018, 10:159-168

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial

Hu YH, Wei JW, Chang H, Xiao WW, Lin JZ, Cai MY, Cai PQ, Kong LH, Chen G, Pan ZZ, Zeng ZF, Ding PR, Gao YH

Cancer Management and Research 2018, 10:4363-4369

Clinicopathological characteristics and prognostic factors for primary thyroid lymphoma: report on 28 Chinese patients and results of a population-based study

Chen E, Wu Q, Jin Y, Jin W, Cai Y, Wang Q, Zhang X, Wang O, Li Q, Zheng Z

Cancer Management and Research 2018, 10:4411-4419

Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels

Zhao X, Pan J, Li W, Yang W, Qin L, Pan Y

International Journal of Nanomedicine 2018, 13:6207-6221

Synthesis of ginsenoside Re-based carbon dots applied for bioimaging and effective inhibition of cancer cells

Yao H, Li J, Song Y, Zhao H, Wei Z, Li X, Jin Y, Yang B, Jiang J

International Journal of Nanomedicine 2018, 13:6249-6264

Scoping clinicians’ perspectives on pre-treatment multidisciplinary care for young women with breast cancer

Corter AL, Quan ML, Wright FL, Kennedy ED, Simunovic MRI, Shao J, Baxter NN

Journal of Multidisciplinary Healthcare 2018, 11:547-555

Clinical significance and biological roles of cyclins in gastric cancer

Zhang HP, Li SY, Wang JP, Lin J

OncoTargets and Therapy 2018, 11:6673-6685

Synthesis and anticancer activity of dimeric podophyllotoxin derivatives

Zi C, Yang L, Xu F, Dong F, Yang D, Li Y, Ding Z, Zhou J, Jiang Z, Hu J

Drug Design, Development and Therapy 2018, 12:3393-3406

Synthesis and study of cell-penetrating peptide-modified gold nanoparticles

Boussoufi F, Navarro Gallón SM, Chang R, Webster TJ

International Journal of Nanomedicine 2018, 13:6199-6205

Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells

Jiang L, Liang QL, Liang WM, Zhang HJ, Huang J, Yuan GL, Peng XX, Cheng SA, Huang ZG, Zhang XN

OncoTargets and Therapy 2018, 11:6665-6671

Knockdown of RAI14 suppresses the progression of gastric cancer

Chen C, Maimaiti A, Zhang X, Qu H, Sun Q, He Q, Yu W

OncoTargets and Therapy 2018, 11:6693-6703

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Wang XX, Ye FG, Zhang J, Li JJ, Chen QX, Lin PY, Song CG

Cancer Management and Research 2018, 10:4393-4400

Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer

Wu Y, Deng Y, Zhu J, Duan Y, Weng W, Wu XH

OncoTargets and Therapy 2018, 11:6647-6656

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study

Ge LP, Liu XY, Xiao Y, Gou ZC, Zhao S, Jiang YZ, Di GH

Cancer Management and Research 2018, 10:4381-4391

LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1

Zhang D, Li S, Yu W, Chen C, Liu T, Sun Y, Zhao Z, Liu L

Cancer Management and Research 2018, 10:4349-4361

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly

Wu C, Li B, Sun G, Peng C, Xiang D

OncoTargets and Therapy 2018, 11:6617-6624

Severe central obesity or diabetes can replace weight loss in the detection of frailty in obese younger elderly – a preliminary study

Buch A, Keinan-Boker L, Kis O, Carmeli E, Izkhakov E, Ish-Shalom M, Berner Y, Shefer G, Marcus Y, Stern N

Clinical Interventions in Aging 2018, 13:1907-1918

Male accessory breast cancer on the abdominal wall: a case report and literature review

Zhong GB, Ye XQ, Liu JL, Xiao SZ, Huang QH, Wei W

OncoTargets and Therapy 2018, 11:6625-6631

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro

Liu WJ, Wang H, Peng XW, Wang WD, Liu NW, Wang Y, Lu Y

OncoTargets and Therapy 2018, 11:6605-6615

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature

You X, Yang S, Sui J, Wu W, Liu T, Xu S, Cheng Y, Kong X, Liang G, Yao Y

Cancer Management and Research 2018, 10:4297-4310

Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses

Yang GD, Chen QY, Xiao JM, Zhang HL, Wang ZC, Lin XG

Cancer Management and Research 2018, 10:4287-4295

Clinical significance of prognostic score based on age, tumor size, and grade in gastric cancer after gastrectomy

Lu J, Chen Y, Liu Y, Ding J, Piao Z, Liu W

Cancer Management and Research 2018, 10:4279-4286

Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide

Islami M, Zarrabi A, Tada S, Kawamoto M, Isoshima T, Ito Y

International Journal of Nanomedicine 2018, 13:6059-6071

In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells

Hernandez-Delgadillo R, García-Cuellar CM, Sánchez-Pérez Y, Pineda-Aguilar N, Martínez-Martínez MA, Rangel-Padilla EE, Nakagoshi-Cepeda SE, Solís-Soto JM, Sánchez-Nájera RI, Nakagoshi-Cepeda MAA, Chellam, S, Cabral-Romero C

International Journal of Nanomedicine 2018, 13:6089-6097

Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?

Borges JMDM, Oliveira de Carvalho F, Gomes IA, Borges Rosa M, Sousa ACS

Therapeutics and Clinical Risk Management 2018, 14:1887-1895

Nodal regulates bladder cancer cell migration and invasion via the ALK/Smad signaling pathway

Li Y, Zhong W, Zhu M, Hu S, Su X

OncoTargets and Therapy 2018, 11:6589-6597

The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis

Sun D, Hou H, Zhang C, Zhang X

OncoTargets and Therapy 2018, 11:6539-6554

Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling

Huang Z, Cai Y, Yang C, Chen Z, Sun H, Xu Y, Chen W, Xu D, Tian W, Wang H

OncoTargets and Therapy 2018, 11:6579-6587

Evaluation of methotrexate-conjugated gadolinium(III) for cancer diagnosis and treatment

Xu D, Lu ST, Li YS, Baidya A, Mei H, He Y, Wu B

Drug Design, Development and Therapy 2018, 12:3301-3309

Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study

Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M, Yamaguchi Y, Yamakita S, Ueno H, Sawa T, Taguchi T, Hosokawa T, Amaya F

Journal of Pain Research 2018, 11:2197-2206

A novel cross-correlation methodology for assessing biophysical responses associated with pain

Sunwoo J, Chalacheva P, Khaleel M, Shah P, Sposto R, Kato RM, Detterich J, Zeltzer LK, Wood JC, Coates TD, Khoo MCK

Journal of Pain Research 2018, 11:2207-2219

lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma

Wang Y, Zhang F, Wang J, Hu L, Jiang F, Chen J, Chen J, Wang L

Cancer Management and Research 2018, 10:4257-4266

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, Hicks D, Yue BB, Fornara P, Wullich B, Taubert H, Wach S, Lieb V

Cancer Management and Research 2018, 10:4173-4180

Capsaicin-induced TRIB3 upregulation promotes apoptosis in cancer cells

Lin RJ, Wu IJ, Hong JY, Liu BH, Liang RY, Yuan TM, Chuang SM

Cancer Management and Research 2018, 10:4237-4248

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50

Gielchinsky I, Scheltema MJ, Cusick T, Chang J, Shnier R, Moses D, Delprado W, Nguyen Q, Yuen C, Haynes A, Stricker PD

Research and Reports in Urology 2018, 10:145-150

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy

Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S

Cancer Management and Research 2018, 10:4229-4235

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

Grywalska E, Pasiarski M, Góźdź S, Roliński J

OncoTargets and Therapy 2018, 11:6505-6524

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

Quan J, Pan X, Zhao L, Li Z, Dai K, Yan F, Liu S, Ma H, Lai Y

OncoTargets and Therapy 2018, 11:6415-6424

IL-17 induces macrophages to M2-like phenotype via NF-κB

Shen J, Sun X, Pan B, Cao S, Cao J, Che D, Liu F, Zhang S, Yu Y

Cancer Management and Research 2018, 10:4217-4228

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting

Navari RM, Schwartzberg LS

OncoTargets and Therapy 2018, 11:6459-6478

miR-431-5p alters the epithelial-to-mesenchymal transition markers by targeting UROC28 in hepatoma cells

Kong Q, Han J, Deng H, Wu F, Guo S, Ye Z

OncoTargets and Therapy 2018, 11:6489-6503

Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study

Hayashi T, Shimokawa M, Matsuo K, Miyoshi T, Toriyama Y, Yokota C, Taniguchi J, Hanada K, Tsumagari K, Okubo N, Koutake Y, Sakata K, Kawamata Y, Goto T, Tsurusaki Y, Koyabu M

Cancer Management and Research 2018, 10:4249-4255

Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor

Pang N, Li J, Sun A, Yang Z, Cheng S, Qi XR

International Journal of Nanomedicine 2018, 13:5971-5990

Radix Tetrastigma hemsleyani flavone exhibits antitumor activity in colorectal cancer via Wnt/β-catenin signaling pathway

Wu X, Yu N, Zhang Y, Ye Y, Sun W, Ye L, Wu H, Yang Z, Wu L, Wang F

OncoTargets and Therapy 2018, 11:6437-6446

Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief

Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, Grassi E, Cammelli S, Cellini F, Morganti AG

Journal of Pain Research 2018, 11:2169-2178

The regulation of cytokine signaling by retinal determination gene network pathway in cancer

Zheng X, Liu Q, Yi M, Qin S, Wu K

OncoTargets and Therapy 2018, 11:6479-6487

Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway

Chen L, Wang J, Wu J, Zheng Q, Hu J

Drug Design, Development and Therapy 2018, 12:3335-3342

Hypofractionated radiotherapy after conservative surgery may increase low–intermediate grade late fibrosis in breast cancer patients

Digesù C, Deodato F, Macchia G, Cilla S, Pieri M, Zamagni A, Farioli A, Buwenge M, Ferrandina G, Morganti AG

Breast Cancer: Targets and Therapy 2018, 10:143-151

Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer

Kamibeppu T, Yamasaki K, Nakahara K, Nagai T, Terada N, Tsukino H, Mukai S, Kamoto T

Research and Reports in Urology 2018, 10:135-144

Psychological symptoms in adult Saudi Arabian cancer patients: prevalence and association with self-rated oral health

Ahmed AE, Albalawi AN, Qureshey ET, Qureshey AT, Yenugadhati N, AL-Jahdali H, Jazieh AR

Breast Cancer: Targets and Therapy 2018, 10:153-159

D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis

Malaguarnera M, Latteri S, Bertino G, Madeddu R, Catania VE, Currò G, Borzì AM, Drago F, Malaguarnera G

Clinical and Experimental Gastroenterology 2018, 11:373-380

MTHFR C677T and A1298C polymorphisms and lung cancer risk in a female Chinese population

Tong W, Tong G, Jin D, Lv Q

Cancer Management and Research 2018, 10:4155-4161

A novel gene-pair signature for relapse-free survival prediction in colon cancer

Chen P, Wang F, Zhang Z, Nie J, Liu L, Feng J, Zhou R, Wang H, Liu J, Zhao Q

Cancer Management and Research 2018, 10:4145-4153

Prognostic factors for postoperative survival among patients with rhabdomyosarcoma of the limbs

Ren S, Wang Z, Huang X, Sun L, Shao J, Ye Z

Cancer Management and Research 2018, 10:4181-4189

Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer

Chen PF, Wang F, Nie JY, Feng JR, Liu J, Zhou R, Wang HL, Zhao Q

OncoTargets and Therapy 2018, 11:6425-6436

LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer

Wang F, Liang S, Liu X, Han L, Wang J, Du Q

OncoTargets and Therapy 2018, 11:6383-6394

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

Wang X, Xu L, Yin Z, Wang D, Wang Q, Xu K, Zhao J, Zhao L, Yuan Z, Wang P

Cancer Management and Research 2018, 10:4105-4112

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8+ T-cell immune responses

Zhu Y, Wang XY, Zhang Y, Xu D, Dong J, Zhang Z, Yi CH, Jia HL, Yang X

Cancer Management and Research 2018, 10:4113-4123

Elemene treatment for NSCLC with multiple CNS metastases: a case report and literature review

Han YS, Zhang X, Lu Y, Dong Y, Fu H, Zhang B, Gao Y

OncoTargets and Therapy 2018, 11:6377-6382

Baicalin suppresses proliferation, migration, and invasion in human glioblastoma cells via Ca2+-dependent pathway

Zhu Y, Fang J, Wang H, Fei M, Tang T, Liu K, Niu W, Zhou Y

Drug Design, Development and Therapy 2018, 12:3247-3261

Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus

Kaliamurthi S, Selvaraj G, Kaushik AC, Gu KR, Wei DQ

Biologics: Targets and Therapy 2018, 12:107-125

Copper-64: a real theranostic agent

Gutfilen B, Souza SAL, Valentini G

Drug Design, Development and Therapy 2018, 12:3235-3245

The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R

Liang ZG, Lin GX, Yu BB, Su F, Li L, Qu S, Zhu XD

Cancer Management and Research 2018, 10:4125-4134

Adverse events risk associated with regorafenib in the treatment of advanced solid tumors: meta-analysis of randomized controlled trials

Yin X, Yin Y, Shen C, Chen H, Wang J, Cai Z, Chen Z, Zhang B

OncoTargets and Therapy 2018, 11:6405-6414

Cationic graphene oxide nanoplatform mediates miR-101 delivery to promote apoptosis by regulating autophagy and stress

Assali A, Akhavan O, Mottaghitalab F, Adeli M, Dinarvand R, Razzazan S, Arefian E, Soleimani M, Atyabi F

International Journal of Nanomedicine 2018, 13:5865-5886

The effect of coping strategy on quality of life in patients with NSCLC

Chabowski M, Jankowska-Polanska B, Lomper K, Janczak D

Cancer Management and Research 2018, 10:4085-4093

NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells

Wu N, Zhao J, Yuan Y, Lu C, Zhu W, Jiang Q

OncoTargets and Therapy 2018, 11:6369-6376

Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene

Vachtenheim J Jr, Lischke R, Vachtenheim J

OncoTargets and Therapy 2018, 11:6361-6367

Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial

Huang J, Liao W, Zhou J, Zhang P, Wen F, Wang X, Zhang M, Zhou K, Wu Q, Li Q

Cancer Management and Research 2018, 10:4065-4072

Dietary changes in the first 3 years after breast cancer diagnosis: a prospective Chinese breast cancer cohort study

Lei Y, Ho SC, Cheng A, Kwok C, Cheung KL, He Y, Lee CI, Lee R, Yeo W

Cancer Management and Research 2018, 10:4073-4084

Role of exosomal small RNA in prostate cancer metastasis

Zhan F, Shen J, Wang R, Wang L, Dai Y, Zhang Y, Huang X

Cancer Management and Research 2018, 10:4029-4038

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA

Bai X, Yi M, Xia X, Yu S, Zheng X, Wu K

Cancer Management and Research 2018, 10:4039-4050

A ten-long non-coding RNA signature for predicting prognosis of patients with cervical cancer

Shen L, Yu H, Liu M, Wei D, Liu W, Li C, Chang Q

OncoTargets and Therapy 2018, 11:6317-6326

MicroRNA-1225-5p behaves as a tumor suppressor in human glioblastoma via targeting of IRS1

Li D, Chi G, Chen Z, Jin X

OncoTargets and Therapy 2018, 11:6339-6350

Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy

Wang ZX, Li L, Tao FY

Journal of Pain Research 2018, 11:2115-2121

A qualitative study among breast cancer patients on chemotherapy: experiences and side-effects

Nies YH, Mhd Ali A, Abdullah N, Islahudin F, Mohamed Shah N

Patient Preference and Adherence 2018, 12:1955-1964

Self-nanoemulsfiying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis

Dou Y, Zhou J, Wang T, Huang Y, Chen VP, Xie Y, Lin ZX, Gao J, Su Z, Zeng H

International Journal of Nanomedicine 2018, 13:5887-5907

An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility

Huang L, Xu W, Dai L, Yan D, Zhang S, Shi X

Cancer Management and Research 2018, 10:3995-4003

Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation

Yin Y, Zhou L, Zhan R, Zhang Q, Li M

Cancer Management and Research 2018, 10:3985-3993

Young age is an independent adverse prognostic factor in early stage breast cancer: a population-based study

Zhang X, Yang J, Cai H, Ye Y

Cancer Management and Research 2018, 10:4005-4018

Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC

Li B, Li C, Guo M, Shang S, Li X, Xie P, Sun X, Yu J, Wang L

OncoTargets and Therapy 2018, 11:6287-6294

LINC00152 promotes the growth and invasion of oral squamous cell carcinoma by regulating miR-139-5p

Li M, Ning J, Li Z, Wang J, Zhao C, Wang L

OncoTargets and Therapy 2018, 11:6295-6304

Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling

Wang W, Han T, Tong W, Zhao J, Qiu X

OncoTargets and Therapy 2018, 11:6249-6257

Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels

Zheng X, Chen B, Wu JX, Jia AY, Rong WQ, Wang LM, Wu F, Zhao YT, Li YX, Wang WH

Cancer Management and Research 2018, 10:3973-3981

Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis

Zhou C, Feng X, Yuan F, Ji J, Shi M, Yu Y, Zhu Z, Zhang J

Cancer Management and Research 2018, 10:3945-3954

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK

Clinical Epidemiology 2018, 10:1349-1358

KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer

Zhang N, Li Z, Xiao W, Yang F, Gao W, Sun ZG

Cancer Management and Research 2018, 10:3937-3944

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer

Liu Y, Xie L, Wang D, Li D, Xu G, Wang L, Zhou H, Yu Y, Lin Z, Lu H

Cancer Management and Research 2018, 10:3963-3971

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer

Yang Y, Wang D, Jin L, Wu G, Bai Z, Wang J, Yao H, Zhang Z

Cancer Management and Research 2018, 10:3911-3929

Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome

Guo P, Liu PF, Yang JJ, Ren T, Xiang Y

Cancer Management and Research 2018, 10:3955-3961

Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients

de Groot S, Louwé LA, Ramautar AIE, Portielje JEA, Ogilvie AC, Batman E, Fiocco M, Kroep JR

Cancer Management and Research 2018, 10:3931-3935

Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles

Liu J, Cheng H, Han L, Qiang Z, Zhang X, Gao W, Zhao K, Song Y

Drug Design, Development and Therapy 2018, 12:3199-3209

Comparative effects of magnetic and water-based hyperthermia treatments on human osteosarcoma cells

Herea D, Danceanu C, Radu E, Labusca L, Lupu N, Chiriac H

International Journal of Nanomedicine 2018, 13:5743-5751

Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study

Shahhoseini E, Ramachandran P, Patterson WR, Geso M

International Journal of Nanomedicine 2018, 13:5733-5741

Targeted nonviral gene therapy in prostate cancer

Altwaijry N, Somani S, Dufès C

International Journal of Nanomedicine 2018, 13:5753-5767

PLK1 as a potential prognostic marker of gastric cancer through MEK-ERK pathway on PDTX models

Dang SC, Fan YY, Cui L, Chen JX, Qu JG, Gu M

OncoTargets and Therapy 2018, 11:6239-6247

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

Liu F, Shangli Z, Hu Z

OncoTargets and Therapy 2018, 11:6209-6216

SOX2, a stemness gene, induces progression of NSCLC A549 cells toward anchorage-independent growth and chemoresistance to vinblastine

Choe C, Kim H, Min S, Park S, Seo J, Roh S

OncoTargets and Therapy 2018, 11:6197-6207

First-line treatment strategies for newly diagnosed chronic myeloid leukemia: a network meta-analysis

Chen KK, Du TF, Wu KS, Yang W

Cancer Management and Research 2018, 10:3891-3910

CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p

Wang S, Xue X, Wang R, Li X, Li Q, Wang Y, Xie P, Kang Y, Meng R, Feng X

Cancer Management and Research 2018, 10:3881-3890

Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: a SEER data-based study

Wang J, Liu J, Pan H, Jiang C, Liu S, Zhu Z, Fang J, Zheng X, Hong S, Wang S

Cancer Management and Research 2018, 10:3867-3873

Determinants of incident asthma–COPD overlap: a prospective study of 55,110 middle-aged adults

Baarnes CB, Andersen ZJ, Tjønneland A, Ulrik CS

Clinical Epidemiology 2018, 10:1275-1287

Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles

Ait Bachir Z, Huang Y, He M, Huang L, Hou X, Chen R, Gao F

International Journal of Nanomedicine 2018, 13:5657-5671

Silver-doped graphene oxide nanocomposite triggers cytotoxicity and apoptosis in human hepatic normal and carcinoma cells

Ali D, Alarifi S, Alkahtani S, Almeer RS

International Journal of Nanomedicine 2018, 13:5685-5699

Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers

Wang Z, Wei Y, Fang G, Hong D, An L, Jiao T, Shi Y, Zang A

Drug Design, Development and Therapy 2018, 12:3171-3180

CD44 is overexpressed and correlated with tumor progression in gallbladder cancer

He YT, Xue C, Yu Y, Chen JA, Chen XL, Ren F, Ren ZG, Cui GY, Sun RR

Cancer Management and Research 2018, 10:3857-3865

Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy

Fushida S, Kinoshita J, Oyama K, Fujimura T, Tsukada T, Yamaguchi T, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:3833-3839

An expression signature model to predict lung adenocarcinoma-specific survival

Shi X, Tan H, Le X, Xian H, Li X, Huang K, Luo VY, Liu Y, Wu Z, Mo HY, Chen AM, Liang Y, Zhang J

Cancer Management and Research 2018, 10:3717-3732

Scalp metastases as first presentation of pulmonary adenocarcinomas: a case report

Yu Q, Subedi S, Tong Y, Wei Q, Xu H, Wang Y, Gong Y, Shi Y

OncoTargets and Therapy 2018, 11:6147-6151

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer

Li S, Wei W, Jiang Y, Li Q, Huang Q, Yang H, Liu J

Drug Design, Development and Therapy 2018, 12:3085-3093

A targeted therapy for melanoma by graphene oxide composite with microRNA carrier

Liu C, Xie H, Yu JG, Chen X, Tang S, Sun L, Chen X, Peng D, Zhang X, Zhou J

Drug Design, Development and Therapy 2018, 12:3095-3106

Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center

Hefner J, Berberich S, Lanvers E, Sanning M, Steimer AK, Kunzmann V

Patient Preference and Adherence 2018, 12:1875-1887

CPEB4 promotes growth and metastasis of gastric cancer cells via ZEB1-mediated epithelial–mesenchymal transition

Cao G, Chen D, Liu G, Pan Y, Liu Q

OncoTargets and Therapy 2018, 11:6153-6165

Lentivirus-mediated shRNA targeting MUTYH inhibits malignant phenotypes of bladder cancer SW780 cells

Gao Q, Liu Y, Xie H, Zhong Y, Liao X, Zhan H, Zhou Q, Ding M, Yang K, Li A, Liu Y, Mei HB, Cai Z

OncoTargets and Therapy 2018, 11:6101-6109

Distribution of CD4+ and CD8+ exhausted tumor-infiltrating lymphocytes in molecular subtypes of Chinese breast cancer patients

Shi F, Chang H, Zhou Q, Zhao YJ, Wu GJ, Song QK

OncoTargets and Therapy 2018, 11:6139-6145

Number of radiotherapy treatment machines in the population and cancer mortality: an ecological study

Medenwald D, Vordermark D, Dietzel CT

Clinical Epidemiology 2018, 10:1249-1273

Efficacy and safety of de-escalation bone-modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis

Liu C, Wang L, Liu L, Zhuang J, Tang S, Zhang TS, Zhou C, Feng F, Liu R, Zhang J, Zhang T, Gao C, Li H, Li J, Sun C

Cancer Management and Research 2018, 10:3809-3823

Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis

Yan H, Ying Y, Xie H, Li J, Wang X, He L, Jin K, Tang J, Xu X, Zheng X

Cancer Management and Research 2018, 10:3781-3791

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date

Bersanelli M, Leonardi F, Buti S

Cancer Management and Research 2018, 10:3773-3780

Decreased expression of TRIM21 indicates unfavorable outcome and promotes cell growth in breast cancer

Zhou WB, Zhang YY, Zhong CN, Hu JT, Hu H, Zhou DX, Cao MQ

Cancer Management and Research 2018, 10:3687-3696

LINK-A promotes cell proliferation through the regulation of aerobic glycolysis in non-small-cell lung cancer

Zhao W, Li W, Dai W, Huang N, Qiu J

OncoTargets and Therapy 2018, 11:6071-6080

Mini-laparoscopic cholecystectomy with the MiniLap® percutaneous surgical system: a series of 32 patients

Sapalidis K, Kosmidis C, Michalopoulos N, Laskou S, Pavlidis E, Mantalovas S, Giannakidis D, Amaniti A, Koulouris C, Katsaounis A, Munteanu AC, Surlin V, Zarogoulidis P, Kesisoglou I

International Journal of General Medicine 2018, 11:369-371

Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature

Gallo S, Arcidiacono MV, Tisato V, Piva R, Penolazzi L, Bosi C, Feo CV, Gafà R, Secchiero P

OncoTargets and Therapy 2018, 11:6049-6056

Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy

Li L, Zhang S, Xie D, Chen H, Zheng X, Pan D

OncoTargets and Therapy 2018, 11:6111-6118

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer

Fu XM, Zhang Y, Yang J, Qi YL, Ming Y, Sun MM, Shang YM, Yang YH, Zhu XY, Gao QL

OncoTargets and Therapy 2018, 11:6091-6100

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism

Zhao C, Lu E, Hu X, Cheng H, Zhang JA, Zhu X

Cancer Management and Research 2018, 10:3753-3764

Impact of CT slice thickness on volume and dose evaluation during thoracic cancer radiotherapy

Luo H, He Y, Jin F, Yang D, Liu X, Ran X, Wang Y

Cancer Management and Research 2018, 10:3679-3686

Emerging clinical significance of claudin-7 in colorectal cancer: a review

Wang K, Xu C, Li WJ, Ding L

Cancer Management and Research 2018, 10:3741-3752

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection

Zhu S, Tan W, Li W, Zhou R, Wu X, Chen X, Li W, Shang C, Chen Y

Cancer Management and Research 2018, 10:3697-3705

Cancer patients treated with intravenous chemotherapy for the first time. What are their needs? What do they lack? A qualitative–quantitative mixed approach

Garcia MA, Kalecinski J, Oriol M, Bonne A, Lofti M, Espenel S, Tinquaut F, Fournel P, Collard O, Vassal C, Rivoirard R, Regnier V, Chauvin F, Bourmaud A

Patient Preference and Adherence 2018, 12:1853-1861

Feasibility of radical hysterectomy in women with FIGO stage IIB cervical cancer: an observation study of 10-year experience in a tertiary center

Yuan L, Guo JQ, Zhang XC, Chen M, Xu CJ, Yao LQ

OncoTargets and Therapy 2018, 11:5527-5533

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

Stenehjem DD, Tran D, Nkrumah MA, Gupta S

OncoTargets and Therapy 2018, 11:5973-5989

No association between tumor laterality and cardiac-related mortality in breast cancer patients after radiotherapy: a population-based study

Li WH, Zhang ZG, Huang ZR, Zhang W, Li ZB, Qi ZQ

Cancer Management and Research 2018, 10:3649-3656

TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression

Gao C, Qiao T, Zhang B, Yuan S, Zhuang X, Luo Y

OncoTargets and Therapy 2018, 11:5963-5971

Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999–2009

Lund H, Vyberg M, Eriksen HH, Grove A, Jensen AØ, Sunde L

Clinical Epidemiology 2018, 10:1223-1231

Chemotherapeutic drug targeting to lungs by way of microspheres after intravenous administration

Sangi S, SreeHarsha N, Bawadekji A, Al Ali M

Drug Design, Development and Therapy 2018, 12:3051-3060

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report

Cheng Y, Zhang J, Qin SK, Hua HQ

OncoTargets and Therapy 2018, 11:5957-5962

Laparoscopic procedure compared with open radical hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study

Guo J, Yang L, Cai J, Xu L, Min J, Shen Y, Xiong Z, Dong W, Bunyamanop V, Wang Z

OncoTargets and Therapy 2018, 11:5903-5908

The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens

Osborne JM, Flight I, Wilson CJ, Chen G, Ratcliffe J, Young GP

Patient Preference and Adherence 2018, 12:1825-1836

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment

Wong XY, Groothuis-Oudshoorn CGM, Tan CS, van Til JA, Hartman M, Chong KJ, IJzerman MJ, Wee HL

Patient Preference and Adherence 2018, 12:1837-1852

Online information and support needs of young people with cancer: a participatory action research study

Lea S, Martins A, Morgan S, Cargill J, Taylor RM, Fern LA

Adolescent Health, Medicine and Therapeutics 2018, 9:121-135

Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy

Lüftner D, Dell’Acqua V, Selle F, Khalil A, Leonardi MC, De La Torre Tomás A, Shenouda G, Romero Fernandez J, Orecchia R, Moyal D, Seité S

OncoTargets and Therapy 2018, 11:5865-5872

Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth

Wu P, Liu Q, Wang Q, Qian H, Yu L, Liu B, Li R

International Journal of Nanomedicine 2018, 13:5405-5418

Iron–gold alloy nanoparticles serve as a cornerstone in hyperthermia-mediated controlled drug release for cancer therapy

Li Y, Xu M, Dhawan U, Liu WC, Wu KT, Liu X, Lin CP, Zhao G, Wu YC, Chung RJ

International Journal of Nanomedicine 2018, 13:5499-5509

Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy

Wu YP, Li XD, Ke ZB, Chen SH, Chen PZ, Wei Y, Huang JB, Sun XL, Xue XY, Zheng QS, Xu N

Infection and Drug Resistance 2018, 11:1491-1497

Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational “LORENA” study

Redondo A, Ramos Vázquez M, Manso L, Gil Gil MJ, Garau Llinas I, García-Garre E, Rodríguez CA, Chacón JI, López-Vivanco G

OncoTargets and Therapy 2018, 11:5845-5852

Accuracy of a fecal immunochemical test according to outside temperature and travel time

Niedermaier T, Weigl K, Gies A, Hoffmeister M, Brenner H

Clinical Epidemiology 2018, 10:1203-1213

Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapy

Lin HJ, Qiu XK, Zhang B, Zhang JC

OncoTargets and Therapy 2018, 11:5943-5955

Successful treatment of recurrent rectal implantation metastasis of ovarian cancer by natural orifice specimen extraction surgery: a case report

Su H, Li B, Ren W, Bao M, Wang P, Liu Q, Wang X, Zhou Z, Zhou H

OncoTargets and Therapy 2018, 11:5925-5931

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study

Shang X, Li Z, Lin J, Wang H, Wang Z

Cancer Management and Research 2018, 10:3561-3567

Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection

Gao XH, Zhang SS, Chen H, Wang K, Xie W, Wang F

OncoTargets and Therapy 2018, 11:5917-5924

miR-300 rs12894467 polymorphism may be associated with susceptibility to primary lung cancer in the Chinese Han population

Liu Z, Lin Y, Kang S, Xu Q, Xiong W, Cai L, He F

Cancer Management and Research 2018, 10:3579-3588

Perivascular cell coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic colorectal cancer

Jiang C, Huang Y, Lu J, Yang Y, Rao H, Zhang B, He W, Xia L

Cancer Management and Research 2018, 10:3589-3597

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Mao Y, Feng Q, Zheng P, Yang L, Liu T, Xu Y, Zhu D, Chang W, Ji M, Ren L, Wei Y, He G, Xu J

Cancer Management and Research 2018, 10:3569-3577

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer

Imai H, Saijo K, Komine K, Kawamura Y, Hiraide S, Umegaki S, Okada Y, Ouchi K, Sato Y, Takahashi M, Takahashi S, Shirota H, Takahashi M, Ishioka C

Cancer Management and Research 2018, 10:3629-3636

Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis

Wang Z, Peng S, Xie H, Guo L, Jiang N, Shang Z, Niu Y

Cancer Management and Research 2018, 10:3599-3610

Current insights into matrix metalloproteinases and glioma progression: transcending the degradation boundary

Pullen NA, Pickford AR, Perry MM, Jaworski DM, Loveson KF, Arthur DJ, Holliday JR, Van Meter TE, Peckham R, Younas W, Briggs SEJ, MacDonald S, Butterfield T, Constantinou M, Fillmore HL

Metalloproteinases In Medicine 2018, 5:13-30

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]

Savelloni J, Gunter H, Lee KC, Hsu C, Yi C, Edmonds KP, Furnish T, Atayee RS

Journal of Pain Research 2018, 11:1877-1878

Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case report

Liang LJ, Wen YX, Xia YY, Wang L, Fei JY, Jiang XD

OncoTargets and Therapy 2018, 11:5821-5826

Letter to the editor “Prognostic value of microRNAs in colorectal cancer: a meta-analysis”

Jayaraj R, Kumarasamy C, Gothandam KM

Cancer Management and Research 2018, 10:3501-3503

TMEM119 promotes gastric cancer cell migration and invasion through STAT3 signaling pathway

Zheng P, Wang W, Ji M, Zhu Q, Feng Y, Zhou F, He Q

OncoTargets and Therapy 2018, 11:5835-5844

Expressions and prognostic values of the E2F transcription factors in human breast carcinoma

Liu ZL, Bi XW, Liu PP, Lei DX, Wang Y, Li ZM, Jiang WQ, Xia Y

Cancer Management and Research 2018, 10:3521-3532

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

Tang X, Xu YC, Lu L, Jiao Y, Liu JJ, Wang LL, Zhao HB

Cancer Management and Research 2018, 10:3533-3549

CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer

Chen J, He Q, Liu J, Xiao Y, Xiao C, Chen K, Xie D, Zhang X

Cancer Management and Research 2018, 10:3505-3511

Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy

Ji W, Chandoo A, Guo X, You T, Shao Z, Zheng K, Wang J, Bi J, Smith FG, Tucker ON, Shen X

Cancer Management and Research 2018, 10:3513-3520

Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro

Xie B, Sun LY, Cheng YJ, Zhou J, Zheng JH, Zhang WM

Cancer Management and Research 2018, 10:3551-3560

Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case report

Saito M, Miyashita K, Miura Y, Ogasawara R, Kanaya M, Izumiyama K, Mori A, Kondo T, Tanaka M, Morioka M, Tanaka S

International Journal of General Medicine 2018, 11:363-367

In situ exploration of characteristics of macropinocytosis and size range of internalized substances in cells by 3D-structured illumination microscopy

Jin J, Shen Y, Zhang B, Deng R, Huang D, Lu T, Sun F, Xu S, Liang C

International Journal of Nanomedicine 2018, 13:5321-5333

Modification of the surface of titanium with multifunctional chimeric peptides to prevent biofilm formation via inhibition of initial colonizers

Zhang X, Geng H, Gong L, Zhang Q, Li H, Zhang X, Wang Y, Gao P

International Journal of Nanomedicine 2018, 13:5361-5375

Splenectomy during cytoreductive surgery in epithelial ovarian cancer

Sun H, Bi X, Cao D, Yang J, Wu M, Pan L, Huang H, Chen G, Shen K

Cancer Management and Research 2018, 10:3473-3482

Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer

Kholghi Oskooei V, Geranpayeh L, Omrani MD, Ghafouri-Fard S

Cancer Management and Research 2018, 10:3451-3462

Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer

Wang N, Guo H, Dong Z, Chen Q, Zhang X, Shen W, Bao Y, Wang X

Cancer Management and Research 2018, 10:3463-3471

Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer

Li H, Zhang W, Sun X, Chen J, Li Y, Niu C, Xu B, Zhang Y

Cancer Management and Research 2018, 10:3433-3450

Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity

Asby DJ, Killick-Cole CL, Boulter LJ, Singleton WGB, Asby CA, Wyatt MJ, Barua NU, Bienemann AS, Gill SS

Cancer Management and Research 2018, 10:3483-3500

PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation

Lv JM, Chen L, Gao Y, Huang H, Pan XW, Liu X, Chen M, Qu FJ, Li L, Wang JK, Cui XG, Xu DF

OncoTargets and Therapy 2018, 11:5797-5809

Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle

Gomari H, Forouzandeh Moghadam M, Soleimani M

OncoTargets and Therapy 2018, 11:5753-5762

Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1

Zhu Y, Xing Y, Chi F, Sun W, Zhang Z, Piao D

OncoTargets and Therapy 2018, 11:5743-5752

Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy

Tu J, Zhang H, Yu J, Liufu C, Chen Z

OncoTargets and Therapy 2018, 11:5763-5775

Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers

Zhang H, Zeng J, Tan Y, Lu L, Sun C, Liang Y, Zou H, Yang X, Tan Y

OncoTargets and Therapy 2018, 11:5811-5819

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein

Chen H, Sha H, Zhang L, Qian H, Chen F, Ding N, Ji L, Zhu A, Xu Q, Meng F, Yu L, Zhou Y, Liu B

International Journal of Nanomedicine 2018, 13:5347-5359

Pain quality descriptors and sex-related differences in patients with shoulder pain

Rau CL, Yang JL, Lin JJ, Wu PC, Hou CY, Song CY, Hsieh CL

Journal of Pain Research 2018, 11:1803-1809

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort

Sun D, Ma J, Wang J, Zhang F, Wang L, Zhang S, Chen G, Li X, Du W, Cui P, Hu Y

Therapeutics and Clinical Risk Management 2018, 14:1691-1700

Chemopreventive activity of sulforaphane

Jiang X, Liu Y, Ma L, Ji R, Qu Y, Xin Y, Lv G

Drug Design, Development and Therapy 2018, 12:2905-2913

Volatile anesthetic sevoflurane suppresses lung cancer cells and miRNA interference in lung cancer cells

Wang L, Wang T, Gu JQ, Su HB

OncoTargets and Therapy 2018, 11:5689-5693

Helicobacter pylori promotes gastric epithelial cell survival through the PLK1/PI3K/Akt pathway

Xu W, Huang Y, Yang Z, Hu Y, Shu X, Xie C, He C, Zhu Y, Lu N

OncoTargets and Therapy 2018, 11:5703-5713

NEAT1_2—SFPQ axis mediates cisplatin resistance in liver cancer cells in vitro

Ru Y, Chen XJ, Guo WZ, Gao SG, Qi YJ, Chen P, Feng XS, Zhang SJ

OncoTargets and Therapy 2018, 11:5695-5702

IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446

Jin F, Miao Y, Xu P, Qiu X

OncoTargets and Therapy 2018, 11:5723-5731

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma

Fang H, Liu HM, Wu WH, Liu H, Pan Y, Li WJ

OncoTargets and Therapy 2018, 11:5647-5655

The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma

Wang C, Wang G, Zhang Z, Wang Z, Ren M, Wang X, Li H, Yu Y, Liu J, Cai L, Li Y, Zhang D, Zhang C

OncoTargets and Therapy 2018, 11:5631-5646

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer

Ying Zhi L, Xu Z, Ning L, Jia Jin L, Hai Cui Y, Hong HG, Fang XJ

OncoTargets and Therapy 2018, 11:5677-5688

The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota

Mulvey JJ, Littmann ER, Ling L, McDevitt MR, Pamer EG, Scheinberg DA

International Journal of Nanomedicine 2018, 13:5275-5286

Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study

Blaes AH, Mulrooney DA, Vogel RI, Solovey A, Hebbel R, Peterson BA, Neglia JP, Biewen C, Konety SH, Duprez DA

Vascular Health and Risk Management 2018, 14:205-211

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

Facchinetti F, Bordi P, Leonetti A, Buti S, Tiseo M

Drug Design, Development and Therapy 2018, 12:2857-2873

Podoplanin-positive cancer-associated fibroblasts predict poor prognosis in lung cancer patients

Hu G, Zhong K, Chen W, Wang S, Huang L

OncoTargets and Therapy 2018, 11:5607-5619

MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition

Kang Y, Zhang Y, Sun Y, Wen Y, Sun F

OncoTargets and Therapy 2018, 11:5657-5666

The role of gene sculptor microRNAs in human precancerous lesions

Wang RH, He LY, Zhou SH

OncoTargets and Therapy 2018, 11:5667-5675

Identification of an eight-gene prognostic signature for lung adenocarcinoma

Li S, Xuan Y, Gao B, Sun X, Miao S, Lu T, Wang Y, Jiao W

Cancer Management and Research 2018, 10:3383-3392

The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients

Zhang P, Zhang M, Han R, Zhang K, Ding H, Liang C, Zhang L

Cancer Management and Research 2018, 10:3371-3381

RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses

Motadi LR, Lekganyane MM, Moela P

Cancer Management and Research 2018, 10:3357-3369

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

Zhang SM, Zhu QG, Ding XX, Lin S, Zhao J, Guan L, Li T, He B, Zhang HQ

Cancer Management and Research 2018, 10:3393-3404

Associations of sirtuins with clinicopathological parameters and prognosis in non–small cell lung cancer

Gong J, Wang H, Lou W, Wang G, Tao H, Wen H, Liu Y, Xie Q

Cancer Management and Research 2018, 10:3341-3356

Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?

Gayed I, Salama V, Dawood L, Canfield S, Wan D, Cai C, Joseph U, Amato R

Cancer Management and Research 2018, 10:3317-3324

Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth

Gallardo F, Mariamé B, Gence R, Tilkin-Mariamé AF

Drug Design, Development and Therapy 2018, 12:2805-2814

Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency

Martin JT, Douaisi M, Arsiwala A, Arha M, Kane RS

International Journal of Nanomedicine 2018, 13:5249-5253

Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer

Yu W, Jiang H, Zhang H, Li J

OncoTargets and Therapy 2018, 11:5569-5577

Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Tozuka T, Seike M, Minegishi Y, Kitagawa S, Kato T, Takano N, Hisakane K, Takahashi S, Kobayashi K, Kashiwada T, Sugano T, Takeuchi S, Kunugi S, Noro R, Saito Y, Kubota K, Gemma A

OncoTargets and Therapy 2018, 11:5601-5605

RRM1 expression and the clinicopathological characteristics of patients with non-small cell lung cancer treated with gemcitabine

Chen Y, Huang Y, Chen DM, Wu C, Leng QP, Wang WY, Deng MQ, Zhao YX, Yang XH

OncoTargets and Therapy 2018, 11:5579-5589

Physical activity and sociodemographic variables related to global health, quality of life, and psychological factors in breast cancer survivors

Patsou ED, Alexias GT, Anagnostopoulos FG, Karamouzis MV

Psychology Research and Behavior Management 2018, 11:371-381

Propranolol for the treatment of vascular sarcomas

Wagner MJ, Cranmer LD, Loggers ET, Pollack SM

Journal of Experimental Pharmacology 2018, 10:51-58

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

Wang Y, Tu L, Du C, Xie X, Liu Y, Wang J, Li Z, Jiang M, Cao D, Yan X, Luo F

OncoTargets and Therapy 2018, 11:5559-5567

Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC

Lei Y, Liu Z, Yang W

OncoTargets and Therapy 2018, 11:5551-5557

Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma

Zhang GH, Wu Y, Zhang JS, Fang ZQ, Liu ZX, Xu ZH, Fan YD

OncoTargets and Therapy 2018, 11:5535-5544

Achalasia and esophageal cancer: risks and links

Torres-Aguilera M, Remes Troche JM

Clinical and Experimental Gastroenterology 2018, 11:309-316

Prognostic significance of NANOG expression in solid tumors: a meta-analysis

Zhao LQ, Liu J, Chen S, Fang C, Zhang XQ, Luo ZB

OncoTargets and Therapy 2018, 11:5515-5526

FOXA1 is upregulated in glioma and promotes proliferation as well as cell cycle through regulation of cyclin D1 expression

Zhang C, Yang M, Li Y, Tang S, Sun X

Cancer Management and Research 2018, 10:3283-3293

Expression profiles of long noncoding RNAs in lung adenocarcinoma

Zhao B, Xu H, Ai X, Adalat Y, Tong Y, Zhang J, Yang S

OncoTargets and Therapy 2018, 11:5383-5390

Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells

Huang K, Liu D

OncoTargets and Therapy 2018, 11:5499-5508

Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer

Liu P, Li W, Hu Y, Jiang Y

OncoTargets and Therapy 2018, 11:5485-5498

Three-dimensional tumor cell cultures employed in virotherapy research

Kloker LD, Yurttas C, Lauer UM

Oncolytic Virotherapy 2018, 7:79-93

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy

Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T

Cancer Management and Research 2018, 10:3255-3271

Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KSP, Wu ATH, Shia BC, Wu SY

Cancer Management and Research 2018, 10:3273-3281

IL-17 and colorectal cancer risk in the Middle East: gene polymorphisms and expression

Al Obeed OA, Vaali-Mohammed MA, Alkhayal KA, Bin Traiki TA, Zubaidi AM, Arafah M, Harris RA, Khan Z, Abdulla MH

Cancer Management and Research 2018, 10:2653-2661

Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study

Kharazmi E, Babaei M, Fallah M, Chen T, Sundquist K, Hemminki K

Clinical Epidemiology 2018, 10:1169-1179

A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer

Xu K, Liu B, Ma Y, Xu B, Xing X

Cancer Management and Research 2018, 10:3245-3254

Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis

Liu Y, Kou C, Bai W, Liu X, Song Y, Zhang L, Wang M, Zhang Y, You Y, Yin Y, Jiang X, Xin Y

OncoTargets and Therapy 2018, 11:5465-5483

Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series

Rusz O, Kószó R, Dobi Á, Csenki M, Valicsek E, Nikolényi A, Uhercsák G, Cserháti A, Kahán Z

OncoTargets and Therapy 2018, 11:5459-5463

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China

Ruan GY, Song YY, Dong BH, Mao XD, Lin F, Kang YF, Xu SX, Chen XJ, Wu QB, Sun PM

Cancer Management and Research 2018, 10:3227-3235

Correlation of variable repeat number in the neck regions of DC-SIGN and DC-SIGNR with susceptibility to nasopharyngeal carcinoma in a Chinese population

Ning S, Yao M, Wu Y, Zhou X, Zhong C, Yan K, Wei Z, Xie Y

Cancer Management and Research 2018, 10:3193-3198

Treatment strategies and predicting prognoses in elderly patients with breast cancer

Wang Z, Zhou Z, Li W, Wang W, Xie X, Liu J, Song Y, Dang C, Zhang H

Cancer Management and Research 2018, 10:3207-3218

MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1

Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y, Zeng Q, Chen Z, Li H

OncoTargets and Therapy 2018, 11:5419-5428

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis

Qiao GL, Song LN, Deng ZF, Chen Y, Ma LJ

OncoTargets and Therapy 2018, 11:5451-5457

The potential of CAR T therapy for relapsed or refractory pediatric and young adult B-cell ALL

Forsberg MH, Das A, Saha K, Capitini CM

Therapeutics and Clinical Risk Management 2018, 14:1573-1584

Attitudes of cancer patients and their families toward disclosure of cancer diagnosis in Saudi Arabia: a Middle Eastern population example

Alzahrani AS, Alqahtani A, Alhazmi M, Gaafar R, Bajabir D, Alharbi IM, Alharbi AMF, Kheshaifaty G, Alzahrani A

Patient Preference and Adherence 2018, 12:1659-1666

SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

Yi N, Xiao M, Jiang F, Liu Z, Ni W, Lu C, Ni R, Chen W

OncoTargets and Therapy 2018, 11:5359-5370

RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment

Zhou X, Liu H, Zhao H, Wang T

OncoTargets and Therapy 2018, 11:5397-5405

ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling

Liu B, Xing X, Li X, Guo Q, Xu T, Xu K

Cancer Management and Research 2018, 10:3159-3168

Prognostic value of tumor burden in nasopharyngeal carcinoma

Chen CB, Fei ZD, Huang CX, Ding JM, Chen LS

Cancer Management and Research 2018, 10:3169-3175

Trend in relative survival in squamous cervical cancer by decade from 1983 to 2012: a period analysis

Wu J, Sun H, Wang S, Yan Y, Sun F, Li Y, Yang G, Ma H

Cancer Management and Research 2018, 10:3177-3191

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S

ClinicoEconomics and Outcomes Research 2018, 10:493-500

Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment

Liu Y, Guo Z, Zhao C, Li X, Liu H, Chen J

OncoTargets and Therapy 2018, 11:5339-5347

Apatinib mesylate tablet in the treatment of advanced malignant melanoma

Yang L, Zhu H, Luo P, Chen S, Xu Y, Wang C

OncoTargets and Therapy 2018, 11:5333-5338

Genome-wide profiling reveals cancer-related genes with switched alternative polyadenylation sites in colorectal cancer

Yang X, Wu J, Xu W, Tan S, Chen C, Wang X, Sun J, Kang Y

OncoTargets and Therapy 2018, 11:5349-5357

Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis

Zhuang C, Zheng L, Wang P

OncoTargets and Therapy 2018, 11:5325-5332

Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis

Cui Z, Gao M, Yin Z, Yan L, Cui L

Cancer Management and Research 2018, 10:3141-3148

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3

Li XY, Hong X, Gao XS, Gu XB, Xiong W, Zhao J, Yu HL, Cui M, Xie M, Bai Y, Sun SQ

Cancer Management and Research 2018, 10:3149-3158

E2F3 promotes cancer growth and is overexpressed through copy number variation in human melanoma

Feng Z, Peng C, Li D, Zhang D, Li X, Cui F, Chen Y, He Q

OncoTargets and Therapy 2018, 11:5303-5313

Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells

Niu X, Gao Z, Qi S, Su L, Yang N, Luan X, Li J, Zhang Q, An Y, Zhang S

International Journal of Nanomedicine 2018, 13:4895-4911

Microsurgical treatment of parafalcine meningiomas: a retrospective study of 126 cases

Kong X, Gong S, Lee IT, Yang Y

OncoTargets and Therapy 2018, 11:5279-5285

Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report

Han T, Chen JJ, Luan YT, Chen XX, Yang XD, Zhang Y, Li G, Wang D, Zheng ZD

OncoTargets and Therapy 2018, 11:5287-5291

miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR

Zhang L, Chen Y, Wang H, Zheng X, Li C, Han Z

OncoTargets and Therapy 2018, 11:5293-5302

Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patients

Weberpals J, Jansen L, Silversmit G, Verbeeck J, van der Geest LG, Vissers PAJ, Zadnik V, Brenner H

Clinical Epidemiology 2018, 10:1109-1125

Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis

Li D, Lv H, Hao X, Hu B, Song Y

Cancer Management and Research 2018, 10:3125-3139

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Rocca A, Maltoni R, Bravaccini S, Donati C, Andreis D

Cancer Management and Research 2018, 10:3083-3099

Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data

Musazzi UM, Rocco P, Brunelli C, Bisaglia L, Caraceni A, Minghetti P

Journal of Pain Research 2018, 11:1665-1672

Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium

ElHusseini H, Elkafas H, Abdelaziz M, Halder S, Atabiekov I, Eziba N, Ismail N, El Andaloussi A, Al-Hendy A

International Journal of Women's Health 2018, 10:503-514

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

Guo ZY, Wang F, Di Y, Yao L, Yu XZ, Fu DL, Li J, Jin C

International Journal of Nanomedicine 2018, 13:4869-4880

Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models

Foglietta F, Spagnoli GC, Muraro MG, Ballestri M, Guerrini A, Ferroni C, Aluigi A, Sotgiu G, Varchi G

International Journal of Nanomedicine 2018, 13:4847-4867

Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma

Zhao YY, Tian Y, Liu L, Zhan JH, Hou X, Chen X, Zhou T, Huang Y, Zhang L

Drug Design, Development and Therapy 2018, 12:2655-2663

A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities

Liu Y, Wang Y, Xing J, Li Y, Liu J, Wang Z

Drug Design, Development and Therapy 2018, 12:2645-2654

Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial

Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A

OncoTargets and Therapy 2018, 11:5261-5268

Profile of abemaciclib and its potential in the treatment of breast cancer

Martin JM, Goldstein LJ

OncoTargets and Therapy 2018, 11:5253-5259

Analysis of potential genes associated with primary cilia in bladder cancer

Du E, Lu C, Sheng F, Li C, Li H, Ding N, Chen Y, Zhang T, Yang K, Xu Y

Cancer Management and Research 2018, 10:3047-3056

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy

Schuurhuizen CSEW, Verheul HMW, Braamse AMJ, Buffart LM, Bloemendal HJ, Dekker J, Konings IRHM

Cancer Management and Research 2018, 10:3015-3021

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X

Cancer Management and Research 2018, 10:3069-3082

Multidisciplinary team approach in the management of popliteal artery injury

Cooper N, Roshdy M, Sciarretta JD, Kaufmann C, Duncan S, Davis J, Macedo FI

Journal of Multidisciplinary Healthcare 2018, 11:399-403

Diagnostic value of PD-1 mRNA expression combined with breast ultrasound in breast cancer patients

Fang J, Shao Y, Su J, Wan Y, Bao L, Wang W, Kong F

Therapeutics and Clinical Risk Management 2018, 14:1527-1535

Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura

Song Z, Yang F, Zhang Y, Fan P, Liu G, Li C, Ding W, Zhang Y, Xu X, Ye Y

OncoTargets and Therapy 2018, 11:5227-5238

Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis

Chen D, Wu YS, Lin H, Wang Y, Li L, Zhang T

Cancer Management and Research 2018, 10:2915-2924

Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma

Zhou Q, Deng C, Chen J, Huang K, Liu T, Yao K, Liu ZW, Qin Z, Li Y, Guo S, Ye Y, Zhou F, Huang W, Liu R, Han H

Cancer Management and Research 2018, 10:2983-2995

Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study

Guo Q, Zhang C, Guo X, Tao F, Xu Y, Feng G, Han X, Ren Z, Zhang H, Zhang P, Wang X, Wang G

Cancer Management and Research 2018, 10:2935-2944

TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resection

Gao ZM, Wang RY, Deng P, Ding P, Zheng C, Hou B, Li K

Cancer Management and Research 2018, 10:2925-2933

Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells

Geng Y, Liu J, Xie Y, Jiang H, Zuo K, Li T, Liu Z

Cancer Management and Research 2018, 10:2905-2914

Distinct prognostic values of mRNA expression of glutathione peroxidases in non–small cell lung cancer

Liu K, Jin M, xiao L, Liu H, Wei S

Cancer Management and Research 2018, 10:2997-3005

Radiotherapy for one rectal cancer patient with cirrhosis and moderate to severe thrombocytopenia: a case report

Shi X, Xia H, Zhang W, Li G, Li A

OncoTargets and Therapy 2018, 11:5203-5207

Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1

Zhou P, Cao Y, Liu X, Yu T, Xu Q, You C, Gao X, Wei Y

International Journal of Nanomedicine 2018, 13:4781-4793

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles

Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS

International Journal of Nanomedicine 2018, 13:4817-4830

Second edition of SIMPAR’s “Feed Your Destiny” workshop: the role of lifestyle in improving pain management

De Gregori M, Belfer I, De Giorgio R, Marchesini M, Muscoli C, Rondanelli M, Martini D, Mena P, Arranz LI, Lorente-Cebrián S, Perna S, Villarini A, Salamone M, Allegri M, Schatman ME

Journal of Pain Research 2018, 11:1627-1636

Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients

Choi JB, Lee WK, Lee SG, Ryu H, Lee CR, Kang SW, Jeong JJ, Nam KH, Lee EJ, Chung WY, Jo YS, Lee J

Cancer Management and Research 2018, 10:2883-2891

The role of CCN4/WISP-1 in the cancerous phenotype

Nivison MP, Meier KE

Cancer Management and Research 2018, 10:2893-2903

MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas

Kong X, Gong S, Yan T, Yang Y

Cancer Management and Research 2018, 10:2825-2834

Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models

Zhuang X, Qiao T, Yuan S, Zhang Q, Chen W, Luo Y, Xu G

OncoTargets and Therapy 2018, 11:5133-5142

Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia

Ding L, Zhang W, Yang L, Pelicano H, Zhou K, Yin R, Huang R, Zeng J

OncoTargets and Therapy 2018, 11:5151-5170

HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial

Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B

Clinical Epidemiology 2018, 10:1027-1036

Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells

Rivera-Rodriguez A, Chiu-Lam A, Morozov VM, Ishov AM, Rinaldi C

International Journal of Nanomedicine 2018, 13:4771-4779

Using LC–MS/MS-based targeted proteomics to monitor the pattern of ABC transporters expression in the development of drug resistance

Meng F, Zou L, Zhang T, Jiang L, Ding Y, Yu P, Peng J

Cancer Management and Research 2018, 10:2859-2870

Comprehensive review of fetal adenocarcinoma of the lung

Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF

Lung Cancer: Targets and Therapy 2018, 9:57-63

Utility of trio-based exome sequencing in the elucidation of the genetic basis of isolated syndromic intellectual disability: illustrative cases

Carneiro TNR, Krepischi ACV, Costa SS, Tojal da Silva I, Vianna-Morgante AM, Valieris R, Ezquina SAM, Bertola DR, Otto PA, Rosenberg C

The Application of Clinical Genetics 2018, 11:93-98

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis

Hu B, Shi D, Lv X, Wu F, Chen S, Shao Z

OncoTargets and Therapy 2018, 11:5083-5092

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

Akamine T, Toyokawa G, Tagawa T, Seto T

OncoTargets and Therapy 2018, 11:5093-5101

Breastfeeding rates and barriers: a report from the State of Qatar

Hendaus MA, Alhammadi AH, Khan S, Osman S, Hamad A

International Journal of Women's Health 2018, 10:467-475

Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study

Lima J, Gago P, Rocha M, Grilo I, Gomes R, Luís M, Sarmento T, Teira A, Sousa M, Barbosa M

International Journal of General Medicine 2018, 11:331-336

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement and selection of attributes and levels

Mathijssen EGE, van Heuckelum M, van Dijk L, Vervloet M, Zonnenberg SMT, Vriezekolk JE, van den Bemt BJF

Patient Preference and Adherence 2018, 12:1537-1555

A novel approach to target hypoxic cancer cells via combining β-oxidation inhibitor etomoxir with radiation

Dheeraj A, Agarwal C, Schlaepfer IR, Raben D, Singh R, Agarwal R, Deep G

Hypoxia 2018, 6:23-33

Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1

Dai T, Hu Y, Lv F, Ozawa T, Sun X, Huang J, Han X, Kishi H, Muraguchi A, Jin A

OncoTargets and Therapy 2018, 11:5047-5057

miRNA-543 promotes cell migration and invasion by targeting SPOP in gastric cancer

Xu J, Wang F, Wang X, He Z, Zhu X

OncoTargets and Therapy 2018, 11:5075-5082

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

Huang M, Du H, Zhang L, Che H, Liang C

Cancer Management and Research 2018, 10:2809-2816

Cauda equine syndrome as the primary symptom of leptomeningeal metastases from lung cancer: a case report and review of literature

Liu Y, Wang B, Qian Y, Di D, Wang M, Zhang X

OncoTargets and Therapy 2018, 11:5009-5013

Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study

Mao IC, Lin CY, Wu CL, Kor CT, Chang CC

Therapeutics and Clinical Risk Management 2018, 14:1435-1443

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer

Dong L, Ding H, Li Y, Xue D, Liu Y

Cancer Management and Research 2018, 10:2799-2807

Recent advances in "smart" delivery systems for extended drug release in cancer therapy

Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR

International Journal of Nanomedicine 2018, 13:4727-4745

Genetically engineered drug rhCNB induces apoptosis and cell cycle arrest in both gastric cancer cells and hepatoma cells

Guo Y, Huang Y, Tian S, Xie X, Xing G, Fu J

Drug Design, Development and Therapy 2018, 12:2567-2575

MEK inhibitors for the treatment of NRAS mutant melanoma

Sarkisian S, Davar D

Drug Design, Development and Therapy 2018, 12:2553-2565

Molecular mechanism of activated T cells in breast cancer

Wu J, Li M, Zhang Y, Cai Y, Zhao G

OncoTargets and Therapy 2018, 11:5015-5024

The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients

Na Z, Qiao X, Hao X, Fan L, Xiao Y, Shao Y, Sun M, Feng Z, Guo W, Li J, Li J, Li D

OncoTargets and Therapy 2018, 11:4913-4944

Long non-coding RNA MEG3 suppresses survival, migration, and invasion of cervical cancer

Chen X, Qu J

OncoTargets and Therapy 2018, 11:4999-5007

ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature

Zheng Q, Zheng M, Jin Y, Shen X, Shan L, Shen L, Sun Y, Chen H, Li Y

OncoTargets and Therapy 2018, 11:4991-4998

Uveal metastases in the mid-southeastern United States: a single-institution experience

King BA, Rosenberger EU, Morales-Tirado VM, Wilson MW

Clinical Ophthalmology 2018, 12:1459-1463

The expression profile and clinical application potential of hsa_circ_0000711 in colorectal cancer

Li J, Ni S, Zhou C, Ye M

Cancer Management and Research 2018, 10:2777-2784

Prognostic value of inflammation-based prognostic index in patients with nasopharyngeal carcinoma: a propensity score matching study

Oei RW, Ye L, Kong F, Du C, Zhai R, Xu T, Shen C, Wang X, He X, Kong L, Hu C, Ying H

Cancer Management and Research 2018, 10:2785-2797

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma

Zhang L, Tao L, Guo L, Zhan J, Yuan C, Ma Z, Jiang B, Xiu D

Cancer Management and Research 2018, 10:2767-2775

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer

Jiang C, Zhang Y, Li Y, Lu J, Huang Q, Xu R, Feng Y, Yan S

OncoTargets and Therapy 2018, 11:4979-4990

Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A

Zheng Y, Gao Y, Li X, Si S, Xu H, Qi F, Wang J, Cheng G, Hua L, Yang H

OncoTargets and Therapy 2018, 11:4965-4977

Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma

Shao X, Lu Q, Wang G, Huang W, Yang L, Chen Z

OncoTargets and Therapy 2018, 11:4955-4963

Real-world comparison of the effectiveness and safety of different bowel preparation agents

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir SP

Clinical and Experimental Gastroenterology 2018, 11:289-299

High Spy1 expression predicts poor prognosis in colorectal cancer

Jin Q, Liu G, Bao L, Ma Y, Qi H, Yun Z, Dai Y, Zhang S

Cancer Management and Research 2018, 10:2757-2765

lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis

Chen X, Yang Y, Cao Y, Wu C, Wu S, Su Z, Jin H, Wang D, Zhang G, Fan W, Lin J, Zeng Y, Hu D

Cancer Management and Research 2018, 10:2711-2727

A network-based signature to predict the survival of non-smoking lung adenocarcinoma

Mao Q, Zhang L, Zhang Y, Dong G, Yang Y, Xia W, Chen B, Ma W, Hu J, Jiang F, Xu L

Cancer Management and Research 2018, 10:2683-2693

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes

Manapov F, Käsmann L, Roengvoraphoj O, Dantes M, Schmidt-Hegemann NS, Belka C, Eze C

Lung Cancer: Targets and Therapy 2018, 9:49-55

Incidence and risk factors for insufficient endometrial tissue from endometrial sampling

Aue-aungkul A, Kleebkaow P, Kietpeerakool C

International Journal of Women's Health 2018, 10:453-457

Leading causes of death of women of reproductive age in the Republic of Georgia: findings from the National Reproductive Age Mortality Survey (2014)

Lomia N, Berdzuli N, Sturua, L, Kereselidze M, Topuridze M, Pestvenidze E, Stray-Pedersen B

International Journal of Women's Health 2018, 10:437-452

Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment

Pereira NRC, Loiola RA, Rodrigues SF, de Oliveira CP, Büttenbender SL, Guterres SS, Pohlmann AR, Farsky SH

International Journal of Nanomedicine 2018, 13:4563-4573

Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations

Ghoreishi SM, Khalaj A, Sabzevari O, Badrzadeh L, Mohammadzadeh P, Mousavi Motlagh SS, Bitarafan-Rajabi A, Shafiee Ardestani M

International Journal of Nanomedicine 2018, 13:4671-4683

MicroRNA-21-5p promotes proliferation of gastric cancer cells through targeting SMAD7

Jiang Y, Zhang M, Guo T, Yang C, Zhang C, Hao J

OncoTargets and Therapy 2018, 11:4901-4911

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M, Miyashita T, Tajima H, Ninomiya I, Ohta T

Cancer Management and Research 2018, 10:2729-2742

Proximal shift of colorectal cancer with increasing age in different ethnicities

Yang L, Xiong Z, He W, Xie K, Liu S, Kong P, Jiang C, Guo G, Xia L

Cancer Management and Research 2018, 10:2663-2673

Adenosquamous carcinoma of the lung

Li C, Lu H

OncoTargets and Therapy 2018, 11:4829-4835

Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis

Zhang K, Hong R, Xu F, Xia W, Kaping L, Qin G, Zheng Q, Lu Q, Shi YX, Yuan ZY, Wang SS

Cancer Management and Research 2018, 10:2573-2580

Potential role of LINC00996 in colorectal cancer: a study based on data mining and bioinformatics

Ge H, Yan Y, Wu D, Huang Y, Tian F

OncoTargets and Therapy 2018, 11:4845-4855

Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis

Gao S, Zhao ZY, Wu R, Zhang Y, Zhang ZY

OncoTargets and Therapy 2018, 11:4877-4891

MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer

Gao S, Zhao Z, Wu R, Wu L, Tian X, Zhang Z

OncoTargets and Therapy 2018, 11:4837-4844

PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2

Cheng D, He Z, Zheng L, Xie D, Dong S, Zhang P

OncoTargets and Therapy 2018, 11:4869-4876

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study

Oei RW, Ye L, Huang J, Kong F, Xu T, Shen C, Wang X, He X, Kong L, Hu C, Ying H

OncoTargets and Therapy 2018, 11:4857-4868

Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study

Oweis AO, Alshelleh SA, Daoud AK, Smadi MM, Alzoubi KH

International Journal of Nephrology and Renovascular Disease 2018, 11:211-215

Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies

Wang X, Chen Q, Zhang X, Ren X, Zhang X, Meng L, Liang H, Sha X, Fang X

International Journal of Nanomedicine 2018, 13:4641-4659

sLAG-3 in non-small-cell lung cancer patients’ serum

He Y, Wang Y, Zhao S, Zhao C, Zhou C, Hirsch FR

OncoTargets and Therapy 2018, 11:4781-4784

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer

Li Y, Cui X, Li Y, Zhang T, Li S

Cancer Management and Research 2018, 10:2627-2633

Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case–control study

Yu Y, Fang C, Peng C, Shen S, Xu G, Sun Q, Li L, Su C, Zou X

Cancer Management and Research 2018, 10:2605-2613

Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics

Ding C, Tang W, Fan X, Wu G

OncoTargets and Therapy 2018, 11:4797-4810

Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA

Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J

Cancer Management and Research 2018, 10:2521-2535

An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer

Xue D, Cheng P, Han M, Liu X, Xue L, Ye C, Wang K, Huang J

OncoTargets and Therapy 2018, 11:4755-4768

Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery

Lim C, Moon J, Sim T, Hoang NH, Won WR, Lee ES, Youn YS, Choi HG, Oh K, Oh KT

International Journal of Nanomedicine 2018, 13:4627-4639

MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer

Yue Y, Zhou K, Li J, Jiang S, Li C, Men H

OncoTargets and Therapy 2018, 11:4769-4780

The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials

Guo XX, Wu HL, Shi HY, Su L, Zhang X

Cancer Management and Research 2018, 10:2553-2562

Enhanced anticancer effects of low-dose curcumin with non-invasive pulsed electric field on PANC-1 cells

Lu CH, Lin SH, Hsieh CH, Chen WT, Chao CY

OncoTargets and Therapy 2018, 11:4723-4732

miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression

Cheng H, Dong H, Feng J, Tian H, Zhang H, Xu L

OncoTargets and Therapy 2018, 11:4711-4721

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T

Cancer Management and Research 2018, 10:2537-2551

E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition

Qi P, Lin W, Zhang M, Huang D, Ni S, Zhu X, Bai Q, Sheng W, Du X, Zhou X

Cancer Management and Research 2018, 10:2563-2571

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Fang J, Wang H, Zhou J, Dai W, Zhu Y, Zhou Y, Wang X, Zhou M

Drug Design, Development and Therapy 2018, 12:2497-2508

B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma

Yu TT, Zhang T, Lu X, Wang RZ

OncoTargets and Therapy 2018, 11:4693-4700

Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro

Tian Y, Liu Z, Zhang L, Zhang J, Han X, Wang Q, Cheng W

OncoTargets and Therapy 2018, 11:4785-4795

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus

Cho E, Ryu EJ, Jiang F, Jeon UB, Cho M, Kim CH, Kim M, Kim ND, Hwang TH

Drug Design, Development and Therapy 2018, 12:2467-2474

Drug response to PD-1/PD-L1 blockade: based on biomarkers

Chen Q, Li T, Yue W

OncoTargets and Therapy 2018, 11:4673-4683

Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Chen Y, Liu L

OncoTargets and Therapy 2018, 11:4651-4660

Eyes absent homologue 2 predicts a favorable prognosis in colorectal cancer

Zheng J, Cao F, Huang X, Ramen K, Xu X, Zhu Y, Chang W, Shan Y, Guo A

OncoTargets and Therapy 2018, 11:4661-4671

Adjuvant chemotherapy for stage II colon cancer: who really needs it

Yang Y, Yang Y, Yang H, Wang F, Wang HH, Chen Q, Liu Y, Li AY, Zhang QA

Cancer Management and Research 2018, 10:2509-2520

Effective nivolumab sequential thoracic radiotherapy in elderly patients with advanced squamous cell lung cancer: did radiation therapy play a role? A case report

Lazzari G, Terlizzi A, Porrazzo G, Devicienti S, Perri F, Della Vittoria Scarpati G, Silvano G

OncoTargets and Therapy 2018, 11:4621-4629

CTLA4 tagging polymorphisms and risk of colorectal cancer: a case–control study involving 2,306 subjects

Zou C, Qiu H, Tang W, Wang Y, Lan B, Chen Y

OncoTargets and Therapy 2018, 11:4609-4619

A long noncoding RNA MAP3K1-2 promotes proliferation and invasion in gastric cancer

Wu L, Yin JH, Guan YY, Liu HL, Shen HL, Wang XJ, Han BH, Zhou MW, Gu XD

OncoTargets and Therapy 2018, 11:4631-4639

Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations

Yang X, Shi J, Zhang X, Zhang G, Zhang J, Yang S, Wang J, Ke X, Fu L

Cancer Management and Research 2018, 10:2489-2497

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer

Yi L, Zhang W, Zhang H, Shen J, Zou J, Luo P, Zhang J

Drug Design, Development and Therapy 2018, 12:2455-2466

Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer

He WZ, Yang QX, Xie JY, Kong PF, Hu WM, Yang L, Yang YZ, Xie QK, Jiang C, Yin CX, Guo GF, Qiu HJ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:2499-2507

Bone metastasis predicts poor prognosis of patients with brain metastases from colorectal carcinoma post aggressive treatment

Duan H, He ZQ, Guo CC, Li JH, Wang J, Zhu Z, Sai K, Chen ZP, Jiang XB, Mou YG

Cancer Management and Research 2018, 10:2467-2474

Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma

Luo Y, Xu XC, Shen J, Shi JJ, Lu S, He W, Lei JY, Luo DC

Cancer Management and Research 2018, 10:2449-2455

Clinical and biological implications of IDH1/2 in acute myeloid leukemia with DNMT3Amut

Zhang XP, Shi JL, Zhang JL, Yang XR, Zhang GQ, Yang SY, Wang J, Ke XY, Fu L

Cancer Management and Research 2018, 10:2457-2466

Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study

Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H

OncoTargets and Therapy 2018, 11:4573-4582

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

Hua J, Shi S, Liang D, Liang C, Meng Q, Zhang B, Ni Q, Xu J, Yu X

OncoTargets and Therapy 2018, 11:4591-4608

Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients

Lund E, Nakamura A, Snapkov I, Thalabard JC, Standahl Olsen K, Holden L, Holden M

Clinical Epidemiology 2018, 10:931-940

Case report of a primary prostatic urothelial carcinoma patient with sustained fever

Zhang S, Guo Z

OncoTargets and Therapy 2018, 11:4547-4550

Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas

Zhang W, Wang J, Chai R, Zhong G, Zhang C, Cao W, Yan L, Zhang X, Xu Z

OncoTargets and Therapy 2018, 11:4537-4545

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment

Adamczyk A, Kruczak A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Janecka-Widła A, Majchrzyk K, Cichocka A, Ryś J, Niemiec J

OncoTargets and Therapy 2018, 11:4525-4535

Tracking steps in oncology: the time is now

Purswani JM, Ohri N, Champ C

Cancer Management and Research 2018, 10:2439-2447

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach

Bonfill X, Arevalo-Rodriguez I, Martínez García L, Quintana MJ, Buitrago-García D, Lobos Urbina D, Cordero JA

Cancer Management and Research 2018, 10:2357-2367

TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling

Zhao Y, Song K, Zhang Y, Xu H, Zhang X, Wang L, Fan C, Jiang G, Wang E

Cancer Management and Research 2018, 10:2419-2428

Risk of cancer in patients with thyroid disease and venous thromboembolism

Christensen DH, Veres K, Ording AG, Jørgensen JOL, Cannegieter SC, Thomsen RW, Sørensen HT

Clinical Epidemiology 2018, 10:907-915

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation

Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N

Therapeutics and Clinical Risk Management 2018, 14:1361-1368

Cancer/testis antigens (CTAs) expression in resected lung cancer

Jin S, Cao S, Li J, Meng Q, Wang C, Yao L, Lang Y, Cao J, Shen J, Pan B, Hu J, Yu Y

OncoTargets and Therapy 2018, 11:4491-4499

Melittin induces NSCLC apoptosis via inhibition of miR-183

Gao D, Zhang J, Bai L, Li F, Dong Y, Li Q

OncoTargets and Therapy 2018, 11:4511-4523

Cordycepin induces apoptosis in human pancreatic cancer cells via the mitochondrial-mediated intrinsic pathway and suppresses tumor growth in vivo

Zhang Y, Zhang XX, Yuan RY, Ren T, Shao ZY, Wang HF, Cai WL, Chen LT, Wang XA, Wang P

OncoTargets and Therapy 2018, 11:4479-4490

A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma

Zhao M, Liu Z, Dong L, Zhou H, Yang S, Wu W, Lin J

International Journal of Nanomedicine 2018, 13:4433-4443

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance

Chaikomon K, Chattong S, Chaiya T, Tiwawech D, Sritana-Anant Y, Sereemaspun A, Manotham K

Drug Design, Development and Therapy 2018, 12:2361-2369

Development of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancer

Pan JH, Zhou H, Zhu SB, Huang JL, Zhao XX, Ding H, Pan YL

Cancer Management and Research 2018, 10:2289-2301

Lack of association between the risk of prostate cancer and vitamin D receptor Bsm I polymorphism: a meta-analysis of 27 published studies

Kang S, Zhao Y, Wang L, Liu J, Chen X, Liu X, Shi Z, Gao W, Cao F

Cancer Management and Research 2018, 10:2377-2387

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21

Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, Li L, Zou C, Chan FL, Zhou Y

Cancer Management and Research 2018, 10:2389-2400

Oncolytic virus and PD-1/PD-L1 blockade combination therapy

Chen CY, Hutzen B, Wedekind MF, Cripe TP

Oncolytic Virotherapy 2018, 7:65-77

Influence of oncology nurses’ empathy on lung cancer patients’ cellular immunity

Yang N, Xiao H, Cao Y, Li S, Yan H, Wang Y

Psychology Research and Behavior Management 2018, 11:279-287

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum]

Zhang T, Feng F, Zhao W, Tian J, Yao Y, Zhou C, Dong S, Wang C, Zang C, Lv Q, Sun C

OncoTargets and Therapy 2018, 11:4449-4450

Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma

Zhou J, Han S, Qian W, Gu Y, Li X, Yang K

OncoTargets and Therapy 2018, 11:4451-4459

Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients

Ditsatham C, Chitapanarux I, Somwangprasert A, Watcharachan K, Wongmaneerung P, Charoentum C, Chewaskulyong B, Chakrabandhu S, Onchan W, Teeyasuntranonn A, Sripan P

OncoTargets and Therapy 2018, 11:4443-4447

LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis

Lu W, Tao X, Fan Y, Tang Y, Xu X, Fan S, Huang Y, Yu Y, Luo D

OncoTargets and Therapy 2018, 11:4431-4442

Human leukocyte antigen gene polymorphisms are associated with systemic inflammation in hepatitis B virus-related hepatocellular carcinoma

Wu XL, Li ZY, Bi XY, Zhao H, Zhao JJ, Zhou JG, Han Y, Huang Z, Zhang YF, Cai JQ

Cancer Management and Research 2018, 10:2315-2324

Targeting energy metabolism to eliminate cancer cells

Shahruzaman SH, Fakurazi S, Maniam S

Cancer Management and Research 2018, 10:2325-2335

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway

Xue Y, Yang L, Li J, Yan Y, Jiang Q, Shen L, Yang S, Shen B, Huang R, Yan J, Guo H

OncoTargets and Therapy 2018, 11:4413-4429

Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review

Li XT, Chai J, Wang Z, Lu L, Zhao QY, Zhou J, Ju F

OncoTargets and Therapy 2018, 11:4407-4411

Prognostic role of Toll-like receptors in cancer: a meta-analysis

Wang Q, Zhang X, Xiao T, Pan C, Liu X, Zhao Y

Therapeutics and Clinical Risk Management 2018, 14:1323-1330

Pooling analysis on prognostic value of PHH3 expression in cancer patients

Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z

Cancer Management and Research 2018, 10:2279-2288

Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction

Liao C, Xu D, Liu X, Fang Y, Yi J, Li X, Guo B

International Journal of Nanomedicine 2018, 13:4417-4431

Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer

Liu K, Wang P, Zhu X, Bei Y, Zheng Z, Yan S

Cancer Management and Research 2018, 10:2259-2268

HOXA11-AS: a novel regulator in human cancer proliferation and metastasis

Xue JY, Huang C, Wang W, Li HB, Sun Ming, Xie M

OncoTargets and Therapy 2018, 11:4387-4393

Euphornin reduces proliferation of human cervical adenocarcinoma HeLa cells through induction of apoptosis and G2/M cell cycle arrest

Li XQ, Bai YL, Zhang DL, Jiao HS, He RX

OncoTargets and Therapy 2018, 11:4395-4405

FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway

Zheng R, Liu Q, Wang T, Wang L, Zhang Y

Cancer Management and Research 2018, 10:2269-2278

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity

Peach MS, Trifiletti DM, Vachani C, Arnold-Korzeniowski K, Bach C, Hampshire M, Metz JM, Hill-Kayser CE

Patient Related Outcome Measures 2018, 9:245-252

Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer

Ding MN, Li Y, Yang Y, Zhu K, Che SL, Lin ZH, Chen LY

OncoTargets and Therapy 2018, 11:4367-4375

MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer

Yang S, Sun Z, Zhou Q, Wang W, Wang G, Song J, Li Z, Zhang Z, Chang Y, Xia K, Liu J, Yuan W

Cancer Management and Research 2018, 10:2249-2257

Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery

Yang YS, Zhao Y, Lan JS, Kang YN, Zhang T, Ding Y, Zhang XY, Lu L

International Journal of Nanomedicine 2018, 13:4361-4378

18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients

Zhu W, Zhang Y, Kong L, Huang Y, Zheng J, Wang R, Li M, Yu J

OncoTargets and Therapy 2018, 11:4345-4353

Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles

Zarghami N, Khrapitchev AA, Perez-Balderas F, Sarmiento Soto M, Larkin JR, Bau L, Sibson NR

International Journal of Nanomedicine 2018, 13:4345-4359

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP

Cancer Management and Research 2018, 10:2241-2248

The role of lncRNA CASC2 on prognosis of malignant tumors: a meta-analysis and bioinformatics

Yu L, Chen S, Bao H, Zhang W, Liao M, Liang Q, Cheng X

OncoTargets and Therapy 2018, 11:4355-4365

Identification of prognostic risk factors for esophageal adenocarcinoma using bioinformatics analysis

Dong Z, Wang J, Zhan T, Xu S

OncoTargets and Therapy 2018, 11:4327-4337

Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer

Zhang Y, Xu B, Zhang XP

OncoTargets and Therapy 2018, 11:4263-4270

Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9

Rajasinghe LD, Pindiprolu RH, Gupta SV

OncoTargets and Therapy 2018, 11:4301-4314

Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients

Kim HJ, Jo MJ, Kim BR, Kim JL, Jeong YA, Na YJ, Park SH, Lee SY, Lee DH, Kim BH, Yoo YD, Oh SC

OncoTargets and Therapy 2018, 11:4233-4246

Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissue

Shah PS, Murarka S, Joshi A, Mehta B, Parmar V, Shah N, Patel K, Sands J

Breast Cancer: Targets and Therapy 2018, 10:121-129

Three-photon imaging using defect-induced photoluminescence in biocompatible ZnO nanoparticles

Raghavendra AJ, Gregory WE, Slonecki TJ, Dong Y, Persaud I, Brown JM, Bruce TF, Podila R

International Journal of Nanomedicine 2018, 13:4283-4290

Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics

Gan S, Lin Y, Feng Y, Shui L, Li H, Zhou G

International Journal of Nanomedicine 2018, 13:4263-4281

Facile fabrication of hypericin-entrapped glyconanoparticles for targeted photodynamic therapy

Shao C, Shang K, Xu H, Zhang Y, Pei Z, Pei Y

International Journal of Nanomedicine 2018, 13:4319-4331

Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect

Yang X, Fan B, Gao W, Li L, Li T, Sun J, Peng X, Li X, Wang Z, Wang B, Zhang R, Xie J

International Journal of Nanomedicine 2018, 13:4333-4344

Profiles of differentially expressed circRNAs in esophageal and breast cancer

Shi P, Sun J, He B, Song H, Li Z, Kong W, Wang J, Wang JM, Xue H

Cancer Management and Research 2018, 10:2207-2221

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Shen Y, Li W

Drug Design, Development and Therapy 2018, 12:2285-2292

Bioengineering the spider silk sequence to modify its affinity for drugs

Kucharczyk K, Weiss M, Jastrzebska K, Luczak M, Ptak A, Kozak M, Mackiewicz A, Dams-Kozlowska H

International Journal of Nanomedicine 2018, 13:4247-4261

Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer

Zhu L, Zheng X, Du Y, Xing Y, Xu K, Cui L

OncoTargets and Therapy 2018, 11:4207-4220

Super analgesia of intrathecal morphine may be related to ABCB1 (MDR1) gene polymorphism

Qin WJ, Liu BT, Deng A, Liu Y, Zhang XL, Zhang L

Journal of Pain Research 2018, 11:1355-1357

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Development of a pictorial scale for assessing functional interference with chronic pain: the Pictorial Pain Interference Questionnaire

Cook AJ, Roberts DA, Nelson KC, Clark BR, Parker BE Jr

Journal of Pain Research 2018, 11:1343-1354

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

Sun F, Peng HX, Gao QF, Li SQ, Zhang J, Chen QG, Jiang YH, Zhang L, Wang XZ, Ying HQ

Cancer Management and Research 2018, 10:2151-2161

Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis

Que Y, Liang Y, Zhao JJ, Ding Y, Peng RQ, Guan YX, Zhang X

Cancer Management and Research 2018, 10:2141-2150

DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway

Ge H, Liang C, Li Z, An D, Ren S, Yue C, Wu J

OncoTargets and Therapy 2018, 11:4177-4187

Progress in the treatment of solid tumors with apatinib: a systematic review

Zhao D, Hou H, Zhang X

OncoTargets and Therapy 2018, 11:4137-4147

SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells

Yang L, Xie N, Huang J, Huang H, Xu S, Wang Z, Cai J

OncoTargets and Therapy 2018, 11:4197-4206

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis

Zheng T, Li D, He Z, Feng S, Zhao S

OncoTargets and Therapy 2018, 11:4167-4175

Expression of protein disulfide isomerase A3 precursor in colorectal cancer

Yang Z, Liu J, Shi Q, Chao Y, Di Y, Sun J, Zhang J, Huang L, Guo H, He C

OncoTargets and Therapy 2018, 11:4159-4166

Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer

Bayramov B, Gunes S, Buyukalpelli R, Aydın O, Henkel R

OncoTargets and Therapy 2018, 11:4189-4196

Differential diagnostic value of 18F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging

He X, Zhao L, Guo X, Zhao L, Wu J, Huang J, Sun L, Xie C, Chen H

Cancer Management and Research 2018, 10:2105-2115

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis

Li MX, Jin LT, Wang TJ, Feng YJ, Pan CP, Zhao DM, Shao J

OncoTargets and Therapy 2018, 11:4105-4112

Pleiotropic functions of miR107 in cancer networks

Luo Z, Zheng Y, Zhang W

OncoTargets and Therapy 2018, 11:4113-4124

Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis

Sun C, Zhu J, Wu B, Chen J, Zhu Z, Cai P, Guo W, Gu Z, Wang J, Huang S

Cancer Management and Research 2018, 10:2125-2139

Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement

Seto K, Kuroda H, Yoshida T, Sakata S, Mizuno T, Sakakura N, Hida T, Yatabe Y, Sakao Y

Cancer Management and Research 2018, 10:2117-2124

Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes

Shi M, Zhang J, Li X, Pan S, Li J, Yang C, Hu H, Qiao M, Chen D, Zhao X

International Journal of Nanomedicine 2018, 13:4209-4226

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection

Deng YX, Peng JH, Zhao YJ, Sui QQ, Zhao RX, Lu ZH, Qiu MZ, Lin JZ, Pan ZZ

Cancer Management and Research 2018, 10:2083-2094

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection

Peng J, Li C, Wang F, Zhang H, Xiao W, Li H, Lu Z, Pan Z, Wu X, Zhang R

Cancer Management and Research 2018, 10:2095-2103

Quantifying the prognostic significance of microRNA-17/17-5P in cancers: a meta-analysis based on published studies

Duan F, Yang Y, Liu W, Zhao J, Song X, Li L, Li F

Cancer Management and Research 2018, 10:2055-2069

TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma

Yu S, Xu T, Dai J, Ma M, Tang H, Chi Z, Si L, Cui C, Sheng X, Kong Y, Guo J

OncoTargets and Therapy 2018, 11:4097-4104

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Li X, Li X, Fang X, Yuan Y

OncoTargets and Therapy 2018, 11:4047-4050

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer

Cochera F, Dinca D, Bordejevic DA, Citu IM, Mavrea AM, Andor M, Trofenciuc M, Tomescu MC

Cancer Management and Research 2018, 10:2071-2081

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer

Jin S, Cao S, Grigorev A, Li J, Meng Q, Wang C, Feng M, Hu J, Jiang F, Yu Y

Cancer Management and Research 2018, 10:2031-2046

Long-term survival effect of the interval between mastectomy and radiotherapy in locally advanced breast cancer

Zhang WW, Wu SG, Sun JY, Li FY, He ZY

Cancer Management and Research 2018, 10:2047-2054

New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab

Bylicki O, Paleiron N, Rousseau-Bussac G, Chouaïd C

OncoTargets and Therapy 2018, 11:4051-4064

miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway

Li C, Zhang J, Ma Z, Zhang F, Yu W

OncoTargets and Therapy 2018, 11:4087-4095

Downregulation and DNA methylation of ECRG4 in gastric cancer

Deng P, Chang XJ, Gao ZM, Xu XY, Sun AQ, Li K, Dai DQ

OncoTargets and Therapy 2018, 11:4019-4028

Clinical and microbiological characteristics and occurrence of Klebsiella pneumoniae infection in Japan

Ikeda M, Mizoguhi M, Oshida Y, Tatsuno K, Saito R, Okazaki M, Okugawa S, Moriya K

International Journal of General Medicine 2018, 11:293-299

MFAP2 promotes epithelial–mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway

Wang JK, Wang WJ, Cai HY, Du BB, Mai P, Zhang LJ, Ma W, Hu YG, Feng SF, Miao GY

OncoTargets and Therapy 2018, 11:4001-4017

Health care use before a diagnosis of primary intracranial tumor: a Danish nationwide register study

Nygaard C, Jensen H, Christensen J, Vedsted P

Clinical Epidemiology 2018, 10:809-829

A case report of toxic epidermal necrolysis associated with AZD-9291

Wang J, Cheng XY, Lu Y, Zhou BR

Drug Design, Development and Therapy 2018, 12:2163-2167

Neuropilin-1 expression is associated with lymph node metastasis in breast cancer tissues

Seifi-Alan M, Shams R, Bandehpour M, Mirfakhraie R, Ghafouri-Fard S

Cancer Management and Research 2018, 10:1969-1974

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma

Wang WP, Li N, Zhang YY, Gao YT, Sun YC, Ge L, Wu LY

Cancer Management and Research 2018, 10:1959-1968

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma

Chen H, Zhang Y, Li S, Li N, Chen Y, Zhang B, Qu C, Ding H, Huang J, Dai M

Cancer Management and Research 2018, 10:1947-1958

Influence of socioeconomic factors and region of residence on cancer stage of malignant melanoma: a Danish nationwide population-based study

Ibfelt EH, Steding-Jessen M, Dalton SO, Lundstrøm SL, Osler M, Hölmich LR

Clinical Epidemiology 2018, 10:799-807

Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery

Ngamcherdtrakul W, Sangvanich T, Reda M, Gu S, Bejan D, Yantasee W

International Journal of Nanomedicine 2018, 13:4015-4027

Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study

Nakatsukasa K, Koyama H, Ouchi Y, Sakaguchi K, Fujita Y, Matsuda T, Kato M, Konishi E, Taguchi T

Therapeutics and Clinical Risk Management 2018, 14:1213-1218

The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro

Wu T, Cui H, Xu Y, Du Q, Zhao E, Cao J, Nie L, Fu G, Ren A

OncoTargets and Therapy 2018, 11:3989-4000

Increased expression of antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal cancer and is negatively correlated with its sense transcript

Li C, Li W, Zhang YL, Zhang X, Liu T, Zhang Y, Yang YM, Wang LL, Pan HW, Ji J, Wang CX

OncoTargets and Therapy 2018, 11:3969-3978

SIRT4 acts as a tumor suppressor in gastric cancer by inhibiting cell proliferation, migration, and invasion

Sun H, Huang D, Liu G, Jian F, Zhu J, Zhang L

OncoTargets and Therapy 2018, 11:3959-3968

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma

Yu Y, Ke L, Lv X, Ling Y, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y

Cancer Management and Research 2018, 10:1935-1946

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors

Chen H, Lu A, Zhang X, Gui L, Wang YN, Wu J, Feng H, Peng S, Zhao M

Drug Design, Development and Therapy 2018, 12:2097-2110

Overexpression of DJ-1 correlates with aggressive clinicopathological characteristics and poor prognosis in malignant tumors: a meta-analysis

Wang Q, Li F, Shi W, Zhang Q, Wang J, Yan X, Chai L, Li M

OncoTargets and Therapy 2018, 11:3931-3942

Rising trends in pancreatic cancer incidence and mortality in 2000–2014

Wu W, He XK, Yang L, Wang Q, Bian X, Ye J, Li Y, Li L

Clinical Epidemiology 2018, 10:789-797

Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP -2 and -9 in endometrial polyps and endometrial cancer type I

Peres GF, Spadoto-Dias D, Bueloni-Dias FN, Leite NJ, Elias LV, Domingues MA, Padovani CR, Dias R

OncoTargets and Therapy 2018, 11:3949-3958

Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study

Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ

Cancer Management and Research 2018, 10:1927-1934

Safety and efficacy of durvalumab (MEDI4736) in various solid tumors

Yang H, Shen K, Zhu C, Li Q, Zhao Y, Ma X

Drug Design, Development and Therapy 2018, 12:2085-2096

The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study

Song W, Yu JW, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Kang ES, Jeon HG

OncoTargets and Therapy 2018, 11:3883-3889

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression

Zhang H, Lian Z, Sun G, Liu R, Xu Y

OncoTargets and Therapy 2018, 11:3853-3867

MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer

Yuan HL, Wang T, Zhang KH

OncoTargets and Therapy 2018, 11:3891-3900

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ

OncoTargets and Therapy 2018, 11:3869-3882

The role of histone lysine methyltransferase NSD3 in cancer

Han X, Piao L, Zhuang Q, Yuan X, Liu Z, He X

OncoTargets and Therapy 2018, 11:3847-3852

Prognostic significance of Ki67 expression and the derived neutrophil–lymphocyte ratio in nasopharyngeal carcinoma

Zhao L, Chen H, Hu B, Zhang H, Lin Q

Cancer Management and Research 2018, 10:1919-1926

Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery

Smilowitz HM, Meyers A, Rahman K, Dyment NA, Sasso D, Xue C, Oliver DL, Lichtler A, Deng X, Ridwan SM, Tarmu LJ, Wu Q, Salner AL, Bulsara KR, Slatkin DN, Hainfeld JF

International Journal of Nanomedicine 2018, 13:3937-3948

The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance

Okazaki M, Fushida S, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Ninomiya I, Harada S, Ohta T

Cancer Management and Research 2018, 10:1865-1874

Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation

Li M, Luo H, Zhang W, He K, Chen Y, Liu J, Chen J, Wang D, Hao L, Ran H, Zheng Y, Wang Z, Li P

International Journal of Nanomedicine 2018, 13:3907-3920

miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA

Ni S, Weng W, Xu M, Wang Q, Tan C, Sun H, Wang L, Huang D, Du X, Sheng W

OncoTargets and Therapy 2018, 11:3835-3845

Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R

Lin G, Yu B, Liang Z, Li L, Qu S, Chen K, Zhou L, Lu Q, Sun Y, Zhu X

OncoTargets and Therapy 2018, 11:3805-3815

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study

Yang P, Wang M, Tian T, Feng Y, Zheng Y, Yang T, Li H, Lin S, Xu P, Deng Y, Hao Q, Li N, Guan F, Dai Z

Cancer Management and Research 2018, 10:1791-1798

Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists

Gilmore J, D'Amato S, Griffith N, Schwartzberg L

Cancer Management and Research 2018, 10:1827-1857

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation

Karavana SY, Ay Şenyiğit Z, Çalışkan Ç, Sevin G, İlem Özdemir D, Erzurumlu Y, Şen S, Baloğlu E

Drug Design, Development and Therapy 2018, 12:1959-1975

Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer

Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji B, Zhang Y, Zhang C, Sun Y, Zhu C, Sun Y

OncoTargets and Therapy 2018, 11:3765-3774

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer

Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J

OncoTargets and Therapy 2018, 11:3785-3792

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X, Gan X, Xu Q, Tan N

Cancer Management and Research 2018, 10:1799-1806

Intake of glucosinolates and risk of coronary heart disease in three large prospective cohorts of US men and women

Ma L, Liu G, Zong G, Sampson L, Hu FB, Willett WC, Rimm EB, Manson JE, Rexrode KM, Sun Q

Clinical Epidemiology 2018, 10:749-762

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

Wolf GT, Moyer JS, Kaplan MJ, Newman JG, Egan JE, Berinstein NL, Whiteside TL

OncoTargets and Therapy 2018, 11:3731-3746

Primary effusion lymphoma: current perspectives

Narkhede M, Arora S, Ujjani C

OncoTargets and Therapy 2018, 11:3747-3754

Targeted therapy and immunotherapy for platinum-refractory advanced ovarian adenosquamous carcinoma: a case report

Li A, Sun S, Song T, Li X, Cheng W, Yao R, Zhang D, Cai Z, Zhang J, Zhai D, Yu C

OncoTargets and Therapy 2018, 11:3705-3711

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?

Mudduwa LKB, Wijayaratne GB, Peiris HH, Gunasekera SN, Abeysiriwardhana D, Liyanage N

International Journal of Women's Health 2018, 10:329-335

Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy

Cheng XY, Li DJ, Lin AQ, Xu J, Wu L, Gu HJ, Huang ZY, Liu JY, Zhang YM, Yin XF

International Journal of Nanomedicine 2018, 13:3661-3677

Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer

Hu B, Yan Y, Tong F, Xu L, Zhu J, Xu G, Shen R

International Journal of Nanomedicine 2018, 13:3625-3640

Trends in intensive care unit admissions of COPD patients from 2003 to 2013 in Taiwan

Liao KM, Chen YC, Cheng KC, Wang JJ, Ho CH

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2007-2012

Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014)

Wang Y, Yang L, Zhou M, Shen L, Zhang J, Deng W, Liang L, Hu R, Yang W, Yao Y, Zhang Z

Cancer Management and Research 2018, 10:1735-1747

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S

Cancer Management and Research 2018, 10:1749-1761

An uncommon granulocytic sarcoma of the breast: a case report and literature review

Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y

OncoTargets and Therapy 2018, 11:3685-3690

Role of accelerated aging in limb muscle wasting of patients with COPD

Lakhdar R, McGuinness D, Drost EM, Shiels PG, Bastos R, MacNee W, Rabinovich RA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1987-1998

Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines

Nel M, Joubert AM, Dohle W, Potter BVL, Theron AE

Drug Design, Development and Therapy 2018, 12:1881-1904

Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma

Ma Y, Luo YQ, Lin N, Lv YZ, Zhou Y, Li B, Han KN, Jiang S, Gao JJ

OncoTargets and Therapy 2018, 11:3659-3670

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma

Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T

Cancer Management and Research 2018, 10:1713-1726

The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study

Tang LY, Zhang MX, Lu DH, Chen YX, Liu ZG, Wu SG

Cancer Management and Research 2018, 10:1727-1734

miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants

Chen Y, Tang W, Liu C, Lin J, Wang Y, Zhang S, Chen G, Zheng X

Cancer Management and Research 2018, 10:1657-1664

Review: propensity score methods with application to the HELP clinic clinical study

Rai SN, Wu X, Srivastava DK, Craycroft JA, Rai JP, Srivastava S, James RF, Boakye M, Bhatnagar A, Baumgartner R

Open Access Medical Statistics 2018, 8:11-23

lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S

OncoTargets and Therapy 2018, 11:3649-3657

The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer

Guo X, Zhang C, Guo Q, Xu Y, Feng G, Li L, Han X, Lu F, Ma Y, Wang X, Wang G

Cancer Management and Research 2018, 10:1639-1646

Decreased expression of TRPV1 in renal cell carcinoma: association with tumor Fuhrman grades and histopathological subtypes

Wu YY, Liu XY, Zhuo DX, Huang HB, Zhang FB, Liao SF

Cancer Management and Research 2018, 10:1647-1655

Cancer risk assessment in modern radiotherapy workflow with medical big data

Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y

Cancer Management and Research 2018, 10:1665-1675

Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis

Yan H, Xie H, Ying Y, Li J, Wang X, Xu X, Zheng X

Cancer Management and Research 2018, 10:1627-1638

Role of key players in paradigm shifts of prostate cancer bone metastasis

Sohail A, Sherin L, Butt SI, Javed S, Li Z, Iqbal S, Be'g OA

Cancer Management and Research 2018, 10:1619-1626

Clinical empathy with cancer patients: a content analysis of oncology nurses’ perception

Rohani C, Sedaghati Kesbakhi M, Mohtashami J

Patient Preference and Adherence 2018, 12:1089-1098

Optimal management of resected gastric cancer

Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R

Cancer Management and Research 2018, 10:1605-1618

Global time trends in the incidence of esophageal squamous cell carcinoma

Wang QL, Xie SH, Wahlin K, Lagergren J

Clinical Epidemiology 2018, 10:717-728

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs

Clement S, Chen W, Deng W, Goldys EM

International Journal of Nanomedicine 2018, 13:3553-3570

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

De Luca R, Blasi L, Alù M, Gristina V, Cicero G

Drug Design, Development and Therapy 2018, 12:1769-1775

The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER

Tang J, Kong D, Cui Q, Wang K, Zhang D, Liao X, Gong Y, Wu G

OncoTargets and Therapy 2018, 11:3551-3560

Combined small-cell lung carcinoma

Qin J, Lu H

OncoTargets and Therapy 2018, 11:3505-3511

Prognostic value of miR-17-5p in cancers: a meta-analysis

Kong W, Cheng Y, Liang H, Chen Q, Xiao C, Li K, Huang Z, Zhang J

OncoTargets and Therapy 2018, 11:3541-3549

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R

International Journal of Nanomedicine 2018, 13:3451-3465

Complexes formed by mutant p53 and their roles in breast cancer

Bellazzo A, Sicari D, Valentino E, Del Sal G, Collavin L

Breast Cancer: Targets and Therapy 2018, 10:101-112

Knowledge, attitude, and practice toward the daily management of PICC in critically ill cancer patients discharged from intensive care units

Chen J, Zhao H, Xia Z, Zhang Y, Lv X, Zhou X, Dong X, Li J, Jiang H, Huang Y, Huang H

Cancer Management and Research 2018, 10:1565-1574

Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway

Xia E, Zhou X, Bhandari A, Zhang X, Wang O

Cancer Management and Research 2018, 10:1575-1583

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma

Lyu S, Jiang C, Xu R, Huang Y, Yan S

Cancer Management and Research 2018, 10:1585-1596

An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients

He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP

Cancer Management and Research 2018, 10:1597-1604

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

Peng Y, Huang J, Xiao H, Wu T, Shuai X

International Journal of Nanomedicine 2018, 13:3467-3480

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures

Čeponytė U, Paškevičiūtė M, Petrikaitė V

Cancer Management and Research 2018, 10:1543-1551

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS

Chang J, Xu W, Du X, Hou J

OncoTargets and Therapy 2018, 11:3461-3473

The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis

Li J, Cheng Y, Liu G, Ji Z

OncoTargets and Therapy 2018, 11:3449-3459

STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway

Wang N, He X, Zhou R, Jia G, Qiao Q

OncoTargets and Therapy 2018, 11:3475-3484

Current understanding of reovirus oncolysis mechanisms

Phillips MB, Stuart JD, Rodríguez Stewart RM, Berry JTL, Mainou BA, Boehme KW

Oncolytic Virotherapy 2018, 7:53-63

A nomogram to predict overall surv